| Symbol | BAX |
|---|---|
| Name | BAXTER INTERNATIONAL INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | ONE BAXTER PARKWAY, DEERFIELD, IL 60015 |
| Telephone | 2249482000 |
| Fax | — |
| — | |
| Website | https://www.baxter.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000010456 |
| Description | Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. The company offers contract manufacturing services to pharmaceutical companies. The Hillrom transaction has added basic equipment, including hospital beds, to the portfolio, although about half of Hillroms 2021 revenue came from more digitally connected offerings like its smart beds and Voalte medical communications app. Additional info from NASDAQ: |
2026-07-09 20:10
Baxter - Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors
Read more
2026-06-22 13:00
Baxter - Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact
Read more
2026-06-22 13:00
Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact
Read more
2026-06-03 20:07
Zielinski Anita A 🟢 acquired 13.4K shares of BAXTER INTERNATIONAL INC (BAX) Transaction Date: Jun 01, 2026 | Filing ID: 040231
Read more
2026-06-03 20:06
Wallace Steven P. 🔴 sold 153 shares of BAXTER INTERNATIONAL INC (BAX) at $18.68 Transaction Date: Jun 02, 2026 | Filing ID: 040222
Read more
2026-06-03 20:05
Teaff James 🔴 sold 321 shares of BAXTER INTERNATIONAL INC (BAX) at $18.68 Transaction Date: Jun 02, 2026 | Filing ID: 040214
Read more
2026-05-29 09:28
New Form SD - BAXTER INTERNATIONAL INC <b>Filed:</b> 2026-05-29 <b>AccNo:</b> 0001628280-26-039002 <b>Size:</b> 295 KB
Read more
2026-05-18 20:57
📋 STEPHEN N. OESTERLE REV TRUST (Ex-Affiliate) plans to sell 36K shares of BAXTER INTERNATIONAL INC. (at $17.75 each, total $645K) Filed: May 18, 2026 | ID: 004716
Read more
2026-05-08 18:12
New Form S-8 - BAXTER INTERNATIONAL INC <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001193125-26-214977 <b>Size:</b> 254 KB
Read more
2026-05-07 20:22
Director Wilkes David S. 🟢 acquired 12.8K shares of BAXTER INTERNATIONAL INC (BAX) Transaction Date: May 05, 2026 | Filing ID: 032196
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT00358553 | A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety … | Phase1 | Healthy | Completed | — | — | ClinicalTrials.gov |
| NCT06440317 | Immunothrombosis With Septic Shock Undergoing Renal Replacement Therapy With th… | — | Sepsis | Recruiting | 2026-04-01 | 2027-05-01 | ClinicalTrials.gov |
| NCT07256951 | Gen 2 Battrode Wear Study | Na | Adhesive Wear Time | Recruiting | 2025-11-12 | 2026-05-15 | ClinicalTrials.gov |
| NCT07158333 | Mobile Cardiac Telemetry (MCT) Study | — | Healthy | Completed | 2025-08-05 | 2025-09-12 | ClinicalTrials.gov |
| NCT06937216 | Evaluation of the Effectiveness of The Volara System Determined by Sputum Movem… | Na | Bronchiectasis Adult | Not_Yet_Recruiting | 2025-05-01 | 2025-11-01 | ClinicalTrials.gov |
| NCT06777446 | Elective Adhesiolysis vs. a Wait-and-see Policy to Prevent Recurrences After Co… | Na | Adhesive Small Bowel Obstruction | Not_Yet_Recruiting | 2025-02-01 | 2034-02-01 | ClinicalTrials.gov |
| NCT06695169 | Evaluation of the Integrated Smart Pump-EHR Technology in Eight Adult Acute and… | — | Nurse's Role | Recruiting | 2025-01-31 | 2026-11-11 | ClinicalTrials.gov |
| NCT06842121 | A Bioequivalence Study Comparing Organic Phosphate (Sodium Glycerophosphate Inj… | Phase1 | Parenteral Nutrition | Completed | 2025-01-27 | 2025-05-22 | ClinicalTrials.gov |
| NCT06842134 | A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Nume… | Phase1 | Parenteral Nutrition | Completed | 2025-01-27 | 2025-05-22 | ClinicalTrials.gov |
| NCT06450834 | Ostene in Thoracolumbar Decompression and Fusion Evaluated With VIBE | — | Intraoperative Complications | Enrolling_By_Invitation | 2025-01-17 | 2027-06-01 | ClinicalTrials.gov |
| NCT06633029 | Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry | — | Acute Renal Failure (ARF) | Completed | 2024-12-11 | 2025-06-25 | ClinicalTrials.gov |
| NCT06725108 | Hemodynamic ABI Monitor | — | Traumatic Brain Injury (TBI) | Recruiting | 2024-12-06 | 2026-12-06 | ClinicalTrials.gov |
| NCT05399537 | Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT | Phase3 | Regional Citrate Anticoagulation (RCA) | Recruiting | 2024-07-12 | 2026-12-01 | ClinicalTrials.gov |
| NCT06492031 | Observational Study of the Use of Extraneal in Peritoneal Dialysis in Patients | — | Chronic Renal Failure | Completed | 2024-06-28 | 2026-01-27 | ClinicalTrials.gov |
| NCT05996809 | PMCF Study for COSEAL® in Gynecologic Surgery | — | Adhesion | Completed | 2024-06-03 | 2025-05-08 | ClinicalTrials.gov |
| NCT06065202 | Personalized Nutrition to Improve Recovery in Trauma | Phase2 | Abdominal Trauma | Recruiting | 2024-04-12 | 2027-06-30 | ClinicalTrials.gov |
| NCT06342895 | Interpretation and Optimization of Nutrition in the Intensive Care Units | Na | Nutritional Support | Recruiting | 2024-04-10 | 2025-09-01 | ClinicalTrials.gov |
| NCT06032208 | An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symp… | Na | End Stage Renal Disease | Recruiting | 2024-03-01 | 2025-12-31 | ClinicalTrials.gov |
| NCT06056011 | Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018 | Na | Febrile Illness | Completed | 2024-02-19 | 2025-03-18 | ClinicalTrials.gov |
| NCT06321497 | Extracorporeal Carbon Dioxide Removal Using PrismaLung in Reducing Ventilator I… | — | ARDS, Human | Recruiting | 2024-02-05 | 2028-02-28 | ClinicalTrials.gov |
| NCT05567601 | Doxil/Caelyx BE Study | Phase1 | Ovarian Cancer | Completed | 2023-12-16 | 2024-06-21 | ClinicalTrials.gov |
| NCT06253377 | Continuous Renal Replacement Therapy With Oxiris in Acute Kidney Injury and Sep… | — | Acute Kidney Injury | Unknown | 2023-12-08 | 2025-04-01 | ClinicalTrials.gov |
| NCT05888376 | A Post-Market Clinical Performance and Safety Evaluation of GamCath HighFlow Do… | — | AKI - Acute Kidney Injury | Completed | 2023-12-07 | 2024-04-30 | ClinicalTrials.gov |
| NCT06069518 | Continuous Glucose Monitoring in Patients With Diabetes on Peritoneal Dialysis | — | Kidney Disease, Chronic | Unknown | 2023-11-01 | 2024-11-01 | ClinicalTrials.gov |
| NCT05568914 | Intra Dialytic Parenteral Nutrition and Nutritional Gap Nutritional Gap Identif… | Na | Chronic Kidney Diseases | Unknown | 2023-10-04 | 2024-08-31 | ClinicalTrials.gov |
| NCT05037552 | Benefit of Hemostatic Sealant in Preservation of Ovarian Reserve | Na | Benign Ovarian Cyst | Unknown | 2023-09-30 | 2025-09-30 | ClinicalTrials.gov |
| NCT05729048 | Starling/CRRT Observational Study | — | Hemodynamic Monitoring | Withdrawn | 2023-07-15 | 2025-03-14 | ClinicalTrials.gov |
| NCT05811585 | PMCF Study for ADEPT® in LaparoscopicGynecologic Surgery | — | Adhesion | Completed | 2023-06-26 | 2024-05-31 | ClinicalTrials.gov |
| NCT05721404 | Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Y… | Phase4 | Peritoneal Dialysis | Recruiting | 2023-05-24 | 2027-12-31 | ClinicalTrials.gov |
| NCT05275218 | Effect of an Intervention to Prevent Acute Kidney Injury Versus Standard Care i… | Na | Acute Kidney Injury (Nontraumatic) | Recruiting | 2023-03-22 | 2025-12-01 | ClinicalTrials.gov |
| NCT05450185 | Filter Lifespan in Continuous Renal Replacement Therapy | — | Critically Ill | Recruiting | 2023-03-02 | 2025-08-01 | ClinicalTrials.gov |
| NCT05490940 | Sensory Recovery of Digital Nerves After Microsurgical Epineural Neurorrhaphy A… | Na | Digital Nerve Injuries | Unknown | 2023-03-01 | 2025-12-31 | ClinicalTrials.gov |
| NCT05647161 | BAX602 in Preventing the Adhesion Around Great Cardiac Vessels in Pediatric Pat… | Na | Congenital Heart Disease in Children | Active_Not_Recruiting | 2022-12-08 | 2025-12-31 | ClinicalTrials.gov |
| NCT05309109 | Effect of Medium Cut-Off Hemodialysis on Protein Energy Wasting: The EMCOPEW St… | Na | End Stage Renal Disease (ESRD) | Completed | 2022-09-26 | 2025-03-27 | ClinicalTrials.gov |
| NCT05330767 | DermaClose DUKE Fasciotomy and Wound Study | — | Wound of Skin | Terminated | 2022-08-22 | 2023-11-13 | ClinicalTrials.gov |
| NCT05439174 | Impact of IDPN on Nutrition Markers in Patients Receiving ICHD | — | End-stage Renal Disease | Unknown | 2022-07-15 | 2023-03-30 | ClinicalTrials.gov |
| NCT05309291 | Theranova Randomized, Controlled, Trial (RCT) in China | Na | Chronic Kidney Failure | Completed | 2022-06-22 | 2023-07-06 | ClinicalTrials.gov |
| NCT06556628 | Tympanic Thermometer Study | — | Body Temperature Changes | Active_Not_Recruiting | 2022-04-11 | 2025-05-31 | ClinicalTrials.gov |
| NCT05258487 | The Utility of the Validated Intraoperative Bleeding Scale in Spine Surgery | — | Intraoperative Blood Loss | Completed | 2022-03-01 | 2023-03-14 | ClinicalTrials.gov |
| NCT05309304 | Cefazolin PK Study 3g vs 2g | Phase1 | Healthy | Completed | 2022-02-14 | 2022-08-30 | ClinicalTrials.gov |
| NCT05366010 | Oscillation and Lung Expansion (OLE) Therapy for Treatment of Neuromuscular Dis… | Na | Neuromuscular Diseases | Terminated | 2021-11-04 | 2024-02-27 | ClinicalTrials.gov |
| NCT04957316 | Blood Purification in Patients With Septic Shock | Na | Severe Septic Shock | Unknown | 2021-09-16 | 2025-06-01 | ClinicalTrials.gov |
| NCT04952714 | RRT With a Cytokine Absorption Filter (oXiris ®) in Patients With Septic Shock | — | Acute Kidney Injury | Completed | 2021-09-01 | 2023-11-10 | ClinicalTrials.gov |
| NCT06894446 | Efficacy and Safety of Numeta G13%E Compared to Compounded Parenteral Nutrition… | Phase3 | Malnutrition, Infant | Withdrawn | 2021-08-20 | 2022-05-30 | ClinicalTrials.gov |
| NCT04952792 | Study of Apixaban in Patients Receiving Hemodiafiltration | Phase2 | Atrial Fibrillation | Completed | 2021-05-20 | 2022-12-15 | ClinicalTrials.gov |
| NCT04617093 | Post-Market Study of Low-flow ECCO2R Using PrismaLung+ | Na | Mild to Moderate Acute Respiratory Distress Syndrome | Completed | 2021-04-30 | 2024-01-10 | ClinicalTrials.gov |
| NCT04836026 | Registry for HF20 for Pediatric CRRT Under Emergency Use Authorization | — | Pediatric Kidney Disease | Completed | 2021-01-27 | 2023-11-30 | ClinicalTrials.gov |
| NCT04555044 | Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency … | Phase4 | Essential Fatty Acid Deficiency (EFAD) | Completed | 2021-01-22 | 2022-11-16 | ClinicalTrials.gov |
| NCT04671160 | Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administratio… | — | Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis | Unknown | 2021-01-04 | 2022-09-30 | ClinicalTrials.gov |
| NCT04033029 | Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy Wi… | — | Hemodiafiltration | Completed | 2021-01-01 | 2023-06-30 | ClinicalTrials.gov |
| NCT05101031 | Evaluation of Fluid Volume in Patients With Refractory Hypotension (Fresh-ER) | — | Undifferentated Shock | Completed | 2020-12-18 | 2022-12-17 | ClinicalTrials.gov |
| NCT04648293 | Starling Registry Study | — | Hemodynamic Monitoring | Completed | 2020-11-16 | 2024-02-21 | ClinicalTrials.gov |
| NCT04168814 | Nutritional Status in Locally Advanced or Metastatic Solid Cancer Patients in S… | — | Malnutrition | Completed | 2020-06-10 | 2020-12-15 | ClinicalTrials.gov |
| NCT04165369 | Observational Study to Evaluate the Epidemiology of Surgical-induced Acute Kidn… | — | Acute Kidney Injury (AKI) | Completed | 2020-06-09 | 2022-03-31 | ClinicalTrials.gov |
| NCT04211571 | Theranova Versus High-flux Dialyzer on Preservation of Residual Renal Function | Na | End Stage Renal Disease | Completed | 2020-04-23 | 2023-09-24 | ClinicalTrials.gov |
| NCT04324593 | Healthy Volunteer Study to Evaluate the Impact of Various Common Interventions … | Na | Healthy Volunteers | Terminated | 2020-02-26 | 2020-03-21 | ClinicalTrials.gov |
| NCT04255108 | Validation of a Sensor for Non-invasive Measurement of Stroke Volume and Cardia… | — | Cardiac Failure | Completed | 2020-02-19 | 2020-04-09 | ClinicalTrials.gov |
| NCT04193865 | Hemofilter Life Span, ECLS And/or CRRT | — | Kidney Diseases | Completed | 2020-01-09 | 2024-03-25 | ClinicalTrials.gov |
| NCT04168749 | Efficacy and Safety of Industrially Prepared 3 Chamber Bag Parenteral Nutrition… | — | Weight Gain | Unknown | 2019-11-15 | 2020-05-30 | ClinicalTrials.gov |
| NCT04106310 | Theranova vs High-flux HD Comparison | Na | End Stage Renal Failure on Dialysis | Completed | 2019-11-01 | 2021-06-30 | ClinicalTrials.gov |
| NCT03926949 | Outpatient Preoperative Parenteral Nutrition in Malnourished Surgical Patients | Na | Malnutrition | Recruiting | 2019-10-30 | 2026-07-31 | ClinicalTrials.gov |
| NCT04073771 | A Multiple Centre, Cohort Study of New CRRT Membranes oXiris for Patients With … | — | Acute Kidney Injury Due to Sepsis (Disorder) | Completed | 2019-09-21 | 2021-10-31 | ClinicalTrials.gov |
| NCT04155814 | Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjec… | Phase1 | Bioequivalance | Completed | 2019-09-19 | 2019-12-18 | ClinicalTrials.gov |
| NCT04094038 | The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Qual… | Phase4 | End Stage Renal Disease | Active_Not_Recruiting | 2019-09-16 | 2026-07-01 | ClinicalTrials.gov |
| NCT04083807 | Efficacy and Safety of TISSEEL Lyo Compared to Manual Compression as an Adjunct… | Phase3 | Adjunct to Hemostasis During Vascular Surgery | Completed | 2019-07-10 | 2019-10-22 | ClinicalTrials.gov |
| NCT04058665 | Hemostatic Agent Use and Intraoperative Blood Loss in Lumbar Spine Surgery | — | Blood Loss | Completed | 2019-06-18 | 2022-03-01 | ClinicalTrials.gov |
| NCT04017572 | Optimized vs. Standard Automated Peritoneal Dialysis Regimens Study | Na | End Stage Kidney Disease | Completed | 2019-06-01 | 2020-09-30 | ClinicalTrials.gov |
| NCT03640858 | Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL | Na | End Stage Renal Disease | Completed | 2019-05-08 | 2023-04-30 | ClinicalTrials.gov |
| NCT03884582 | Observational Study Using the CoVa Monitoring System 3 | — | Healthy | Completed | 2019-04-01 | 2019-05-01 | ClinicalTrials.gov |
| NCT03859830 | Clinical Observation of the Performance of Artis Dialysis System, ArtiSet PrePo… | Na | End-Stage Renal Disease | Completed | 2019-01-22 | 2019-11-09 | ClinicalTrials.gov |
| NCT03914586 | The Membrane Adsorbing OXiris Filter in Septic Patients With AKI | — | Sepsis | Unknown | 2019-01-10 | 2020-07-30 | ClinicalTrials.gov |
| NCT03477344 | Dexmedetomidine After Cardiac Surgery for Prevention of Delirium | Phase3 | ICU Delirium | Completed | 2019-01-04 | 2021-06-29 | ClinicalTrials.gov |
| NCT03724045 | Back Side of the Moon: Nutritional Therapy | Na | Nutritional Deficiency | Completed | 2019-01-01 | 2021-09-28 | ClinicalTrials.gov |
| NCT03426943 | Endotoxins and Cytokines Removal During Continuous Hemofiltration With oXiris™ | Na | Septic Shock | Completed | 2018-12-21 | 2022-06-03 | ClinicalTrials.gov |
| NCT03812679 | Performance Evaluation of the AMIA APD Solution Generation System in Patients E… | Na | End Stage Renal Disease (ESRD) | Terminated | 2018-12-20 | 2020-02-19 | ClinicalTrials.gov |
| NCT03736421 | Observational Study to Evaluate Peripheral IntraVenous Analysis (PIVA) in Euvol… | — | Infection | Terminated | 2018-11-10 | 2021-10-01 | ClinicalTrials.gov |
| NCT04002440 | Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry… | Na | Efficacy | Active_Not_Recruiting | 2018-11-08 | 2022-04-01 | ClinicalTrials.gov |
| NCT04286477 | The Immune System in End Stage CKD Patients - Comparison Among Different Modali… | — | End Stage Renal Disease on Dialysis | Unknown | 2018-11-07 | 2022-12-31 | ClinicalTrials.gov |
| NCT03292237 | Intensive Nutrition in Critically Ill Adults | Phase2 | Critical Illness | Completed | 2018-10-15 | 2023-07-31 | ClinicalTrials.gov |
| NCT03547323 | Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine N… | Na | End Stage Renal Disease | Completed | 2018-09-14 | 2019-06-14 | ClinicalTrials.gov |
| NCT03510520 | Comparison of MCO HD on Markers of Vascular Health Compared With On-Line Haemod… | Na | End Stage Renal Disease | Completed | 2018-09-14 | 2019-05-09 | ClinicalTrials.gov |
| NCT03410914 | Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Pos… | Phase2 | Pancreas Cancer | Completed | 2018-08-13 | 2020-10-23 | ClinicalTrials.gov |
| NCT03547336 | Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis Comparing the … | Na | End Stage Renal Disease | Completed | 2018-06-29 | 2020-01-04 | ClinicalTrials.gov |
| NCT03450265 | Hemopatch Compared to TachoSil in Postoperative Air Leak Duration After Pulmona… | Na | Air Leak From Lung | Completed | 2018-06-26 | 2019-07-09 | ClinicalTrials.gov |
| NCT03598387 | Automated Peritoneal Dialysis Versus Intermittent Hemodialysis in Acute Kidney … | Na | Acute Kidney Injury | Unknown | 2018-04-24 | 2022-12-31 | ClinicalTrials.gov |
| NCT03499691 | Exploratory Study to Explore the Safety and Efficacy of the HDx Therapy Using T… | Na | End Stage Renal Disease | Completed | 2018-04-11 | 2018-10-04 | ClinicalTrials.gov |
| NCT03340090 | Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surge… | Na | CHD - Coronary Heart Disease | Unknown | 2018-03-20 | 2019-12-31 | ClinicalTrials.gov |
| NCT03448887 | Cardiovascular Risk Comparison Between Expanded Hemodialysis Using Theranova an… | Na | Kidney Failure, Chronic | Completed | 2018-03-15 | 2020-08-31 | ClinicalTrials.gov |
| NCT03829488 | Better Evidence for Selecting Transplant Fluids | Phase3 | End Stage Kidney Disease | Completed | 2018-01-26 | 2022-05-03 | ClinicalTrials.gov |
| NCT03407287 | Peripheral Venous Analysis (PIVA) for Predicting Volume Responsiveness and Flui… | — | Systemic Inflammatory Response Syndrome | Terminated | 2018-01-08 | 2020-12-01 | ClinicalTrials.gov |
| NCT03392662 | Hemopatch Performance Evaluation: A Prospective Observational Registry | — | Dura Mater Nick Cut or Tear | Completed | 2017-11-29 | 2019-01-28 | ClinicalTrials.gov |
| NCT03463148 | Validation of a Sensor for Non-Invasive Measurements | — | CHF | Completed | 2017-10-24 | 2021-04-19 | ClinicalTrials.gov |
| NCT03257410 | Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients | Na | End Stage Renal Disease | Completed | 2017-09-29 | 2018-10-27 | ClinicalTrials.gov |
| NCT03917186 | Desflurane vs. Sevoflurane in Endovascular Aortic Repair | Phase4 | Renal Failure | Completed | 2017-09-20 | 2021-03-16 | ClinicalTrials.gov |
| NCT02721654 | Plasma-Lyte 148® versUs Saline Study | Phase4 | Hypovolemia | Completed | 2017-09-01 | 2021-06-30 | ClinicalTrials.gov |
| NCT04051840 | Safely and Efficacy of ClinOleic-based Lipid Parenteral Nutrition | Phase1 | Nutritional Supplement Toxicity | Unknown | 2017-07-01 | 2020-06-30 | ClinicalTrials.gov |
| NCT03207802 | Remotely Monitoring Patients With Chronic Conditions in Their Home | — | CHF | Completed | 2017-06-21 | 2017-12-20 | ClinicalTrials.gov |
| NCT03211676 | Comparison of Hemodialysis With Medium Cut-off Dialyzer (Theranova) and High Fl… | Na | End Stage Renal Disease | Completed | 2017-06-07 | 2018-06-14 | ClinicalTrials.gov |
| NCT02252094 | Ultra-protective Pulmonary Ventilation Supported by Low Flow ECCO2R for Severe … | Na | Respiratory Distress Syndrome, Adult | Terminated | 2017-05-22 | 2019-05-31 | ClinicalTrials.gov |
| NCT03323359 | Efficacy and Tolerability of Hemopatch After Hepatic Resection | Na | Hepatectomy | Unknown | 2017-03-17 | 2019-03-17 | ClinicalTrials.gov |
| NCT06200324 | Clinical Outcomes of Ready-to-Use Parenteral Nutrition in Low Birth Weight Newb… | — | Very Low Birth Weight Infant | Completed | 2017-03-01 | 2023-03-31 | ClinicalTrials.gov |
| NCT03058107 | Tight Caloric Control in the Cachectic Oncologic Patient (TiCaCONCO or CoCooN) | Na | Metabolism and Nutrition Disorder | Completed | 2017-02-01 | 2020-07-10 | ClinicalTrials.gov |
| NCT02891070 | Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured D… | Phase3 | Cerebrospinal Fluid Leak | Completed | 2016-10-11 | 2018-08-22 | ClinicalTrials.gov |
| NCT02860130 | Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Con… | Phase3 | Regional Citrate Anticoagulation (RCA) | Terminated | 2016-09-27 | 2018-05-12 | ClinicalTrials.gov |
| NCT02518087 | Increased Adsorption Membranes During Cardiopulmonary Bypass | Na | Cardiopulmonary Bypass | Completed | 2016-09-01 | 2022-01-15 | ClinicalTrials.gov |
| NCT02829489 | International Nutrition Audit in FORegut TuMors | — | Head and Neck Cancer | Completed | 2016-07-26 | 2019-10-15 | ClinicalTrials.gov |
| NCT02831725 | An Observational Cohort Study to Establish Accurate Nutrition Therapy for Criti… | — | Nutrition Therapy for Critical Illness | Unknown | 2016-07-01 | 2019-07-01 | ClinicalTrials.gov |
| NCT02828150 | Integrative Parenteral Nutrition in Cancer Patients | Na | Neoplasms | Completed | 2016-07-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT02556437 | Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidas… | Phase2 | Multifocal Motor Neuropathy | Completed | 2016-06-01 | 2018-05-01 | ClinicalTrials.gov |
| NCT02822898 | Metabolism of Isotonic Versus Hypotonic Maintenance Solutions in Fasting Health… | Phase4 | Healthy Adult Volunteers | Completed | 2016-06-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT03319680 | Benefits of Hemodialysis With Citrate (ABC-treat) Study | Na | Hemodialysis-Induced Symptom | Unknown | 2016-05-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT02960867 | European Registry of Dialysis Treatment of Pediatric Acute Kidney Injury (AKI) | — | Acute Kidney Injury | Completed | 2016-04-01 | 2019-04-01 | ClinicalTrials.gov |
| NCT01793506 | Novel Testing Procedures | — | Immunodeficiencies | Withdrawn | 2016-04-01 | 2017-06-01 | ClinicalTrials.gov |
| NCT02795286 | Automated Setting of Individualized Sodium Technology | Na | End Stage Renal Disease (ESRD) | Completed | 2016-03-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT02640235 | Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Ble… | Na | Bleeding Active | Completed | 2016-02-24 | 2017-10-18 | ClinicalTrials.gov |
| NCT02583347 | Sleep Disturbance in Patients With End-Stage Renal Disease | — | Renal Failure Chronic Requiring Hemodialysis | Unknown | 2015-12-01 | 2018-07-01 | ClinicalTrials.gov |
| NCT02634424 | PK Driven Prophylaxis for Hemophilia A | Na | Hemophilia A | Terminated | 2015-11-25 | 2016-05-12 | ClinicalTrials.gov |
| NCT02491671 | Effectiveness Novel Tissue Sealant, Prevention Prolonged Air Leak (PAL) After L… | Phase3 | Prolonged Air Leak | Completed | 2015-11-24 | 2019-06-30 | ClinicalTrials.gov |
| NCT02561247 | Prismaflex HF20 Set and Prismaflex® System 7.10/7.20 for Acute Continuous Renal… | Na | Acute Kidney Injury in Pediatric Patients | Terminated | 2015-11-10 | 2018-04-06 | ClinicalTrials.gov |
| NCT02564159 | Malnutrition Screening by Muscle Ultrasound in Patients Requiring Mechanical Ve… | Na | Malnutrition | Terminated | 2015-10-30 | 2022-08-16 | ClinicalTrials.gov |
| NCT02568722 | Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: … | Na | Acute Kidney Injury | Completed | 2015-10-01 | 2019-12-01 | ClinicalTrials.gov |
| NCT02719301 | Necklace-Shaped Sensor for Non-Invasive Monitoring of Stroke Volume and Cardiac… | — | Heart Failure | Completed | 2015-09-01 | 2017-01-01 | ClinicalTrials.gov |
| NCT02476994 | Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency … | Phase4 | Essential Fatty Acid Deficiency (EFAD) | Terminated | 2015-05-01 | 2016-10-01 | ClinicalTrials.gov |
| NCT02426580 | Dietary Education Intervention Impact on Dietary Protein Intake in PD | Na | Dietary Modification | Completed | 2015-04-01 | 2018-05-01 | ClinicalTrials.gov |
| NCT02287064 | An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocereb… | Phase1 | Spinocerebellar Ataxias | Unknown | 2015-04-01 | — | ClinicalTrials.gov |
| NCT02428803 | Interactive Videoconferencing in the Provision of Remote Peritoneal Dialysis | — | ESRD | Completed | 2015-04-01 | 2020-11-17 | ClinicalTrials.gov |
| NCT02120404 | Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Es… | Phase2 | Septic Shock | Unknown | 2015-04-01 | 2023-10-01 | ClinicalTrials.gov |
| NCT02377570 | Comparison of the Clinical Performance of 3 THERANOVA 400 Dialyzer Prototypes W… | Na | End Stage Renal Disease | Completed | 2015-03-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02093065 | Platelet Function in Patients With Hemophilia A | — | Hemophilia A | Completed | 2015-03-01 | 2020-02-01 | ClinicalTrials.gov |
| NCT02377622 | Clinical Performance Comparison of 2 THERANOVA 400 Dialyzer Prototypes in HD Wi… | Na | End Stage Renal Disease | Completed | 2015-02-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02368184 | Pilot Study of the CoVa™ Monitoring of Patients With Congestive Heart Failure | — | Congestive Heart Failure | Withdrawn | 2015-02-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT02364791 | A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared … | Phase2 | Thoracic Surgery Lung | Unknown | 2015-02-01 | 2024-12-01 | ClinicalTrials.gov |
| NCT02253693 | Exploratory Pilot Study of Physical Activity Monitoring in Adult Patients With … | — | Hemophilia A, Congenital | Completed | 2015-01-01 | 2017-01-01 | ClinicalTrials.gov |
| NCT02337790 | Necklace-Shaped Sensor for Non-Invasive Remote Monitoring of Vitals | — | Heart Failure | Completed | 2015-01-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02306694 | Prospective Biomarkers of Bone Metabolism in Hemophilia A | Phase3 | Hemophilia | Completed | 2014-12-01 | 2018-04-16 | ClinicalTrials.gov |
| NCT02646436 | Peritoneal Dialysis as an Option of Unplanned Initiation of Chronic Dialysis | Na | Disorders Associated With Peritoneal Dialysis | Unknown | 2014-11-30 | 2018-03-01 | ClinicalTrials.gov |
| NCT02270229 | Evaluation of the Peritoneal Dialysis Program in a Hospital in Chinandega, Nica… | — | Chronic Kidney Disease | Unknown | 2014-11-01 | — | ClinicalTrials.gov |
| NCT02252757 | Assess Measurements of Wireless Cardiac Output Device | — | Congestive Heart Failure | Completed | 2014-09-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT02207751 | Improving Outcomes in Peritoneal Dialysis | — | Chronic Kidney Disease | Withdrawn | 2014-09-01 | 2017-08-01 | ClinicalTrials.gov |
| NCT02212327 | Testing Tissue Sodium Stores in CAPD Patients-Aims 1 & 2 | — | End Stage Renal Disease | Completed | 2014-08-01 | 2016-11-29 | ClinicalTrials.gov |
| NCT02631525 | Recovery Profile Comparison Between Remifentanil-propofol or Desflurane Anesthe… | Phase4 | Delayed Emergence From Anesthesia | Completed | 2014-08-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01975025 | Hemodialysis Frequency and the Calcification Propensity of Serum | Na | Hemodialysis | Completed | 2014-06-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02166359 | Effect of Extraneal (Icodextrin) on Triglyceride Levels in PD Patients | Na | End Stage Renal Disease | Completed | 2014-06-01 | 2019-04-01 | ClinicalTrials.gov |
| NCT02044614 | Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis | Na | Functionally Anuric | Terminated | 2014-05-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT02133313 | Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis | — | End Stage Renal Disease | Completed | 2014-05-01 | 2017-03-01 | ClinicalTrials.gov |
| NCT02140905 | Neck-Worn Monitoring Sensor for - A Study for Monitoring Subjects With Fluid-Ma… | — | Heart Failure | Completed | 2014-04-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT02190877 | Monitoring Subjects With Fluid-Management Issues In the Home Environment | — | Heart Failure | Completed | 2014-04-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT02378350 | Quality of Life on Peritoneal Dialysis Versus Hemodialysis in China | Phase4 | End Stage Renal Disease | Completed | 2014-03-26 | 2017-09-18 | ClinicalTrials.gov |
| NCT02061514 | The Effect of Two Different General Anesthesia Regimes on Postoperative Sleep Q… | Na | Anesthesia | Unknown | 2014-03-01 | 2024-12-01 | ClinicalTrials.gov |
| NCT02066363 | Study of Parenteral Nutrition to Patients With Gastrointestinal Cancer | Na | Gastrointestinal Cancer | Terminated | 2014-03-01 | 2017-08-30 | ClinicalTrials.gov |
| NCT02084381 | PERCI- Medium Cut Off (MCO) | Na | Chronic Kidney Failure | Completed | 2014-02-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT01847534 | Supplemental Parenteral Nutrition in Critically Ill Adults: A Pilot Randomised … | Phase2 | Multiple Organ Failure | Completed | 2014-02-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02019797 | Desflurane-induced Myocardial Protection | Phase4 | Aortic Valve Stenosis | Unknown | 2014-01-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT01985854 | Conversion From Total Intravenous Anesthesia Technique to Desflurane Anesthesia… | Phase4 | Patients Undergoing Elective Craniotomy | Unknown | 2014-01-01 | — | ClinicalTrials.gov |
| NCT01974193 | Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gy… | Phase3 | Gynecologic Cancer | Unknown | 2013-12-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT01986153 | Essential Fatty Acid Status & Immune Function in Parenteral Nutrition Patients | — | Intestinal Failure | Completed | 2013-12-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT02068287 | Esmolol Effects on Heart and Inflammation in Septic Shock | Phase2 | Septic Shock | Unknown | 2013-12-01 | 2017-06-01 | ClinicalTrials.gov |
| NCT02190318 | Residual Renal Function Preservation in Peritoneal Dialysis Patients | Na | Chronic Renal Disease | Unknown | 2013-11-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01962025 | Buttonhole Versus Step Ladder Cannulation in High Dose Hemodialysis | Na | Renal Failure | Completed | 2013-10-01 | 2019-02-11 | ClinicalTrials.gov |
| NCT02083198 | Effects of IV Chloride Content on Outcomes | — | SIRS | Completed | 2013-09-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01912001 | Virtual Ward for Home Dialysis | Na | End Stage Renal Disease | Completed | 2013-09-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT01898689 | Optimizing Local Anesthetic Concentration for Continuous Popliteal-Sciatic Nerv… | Phase4 | Relatively Healthy Volunteers | Completed | 2013-07-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01923480 | Dosing Study of Amino Acids in Seriously Ill Patients | Phase4 | Parenteral Nutrition (No Primary Condition Studied) | Terminated | 2013-07-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01683877 | Efficacy Study of FloSeal in Hemostasis After Laparoscopic Ovarian Cystectomy | Na | Benign Ovarian Tumor | Completed | 2013-06-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT01852747 | Comparison of Actifuse ABX and Local Bone in Spinal Surgery | Phase4 | Scoliosis | Terminated | 2013-03-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT02042768 | Observational Study of Glucose Metabolism and How Dialysate Glucose Affects This | — | Glucose Metabolism Disorders | Completed | 2013-03-01 | 2020-12-31 | ClinicalTrials.gov |
| NCT04085484 | Effects of Two Different Parenteral Nutrition Regimes on Nutrient Intakes, Grow… | — | Nutrition Disorder, Infant | Completed | 2013-01-08 | 2020-11-03 | ClinicalTrials.gov |
| NCT01833962 | A Retrospective Study of Actifuse Synthetic Bone Graft Versus Other Bone Graft … | — | Lumbar Fusion | Unknown | 2013-01-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01772927 | Clinical Tolerance of Numeta 13% | — | Other Preterm Infants | Unknown | 2013-01-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01745991 | Trail to Investigate the Effectiveness of CoSeal in Reducing Adhesions Followin… | — | Biliary Atresia | Unknown | 2012-12-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT01684020 | A Study Evaluating the Efficacy and Safety of ARTISS Human Fibrin Sealant as Us… | Phase2 | Subjects Requesting and Requiring an Open Rhinoplasty | Completed | 2012-11-28 | 2016-04-26 | ClinicalTrials.gov |
| NCT01722695 | Performance Comparison of Revaclear With Larger Dialyzer | Na | Renal Failure Chronic Requiring Hemodialysis | Completed | 2012-11-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT02324283 | Comparison of Emergence and Oxygenation During One-lung Ventilation With Desflu… | Na | Lung Cancer | Active_Not_Recruiting | 2012-10-01 | 2024-12-01 | ClinicalTrials.gov |
| NCT01783626 | Evaluation of Evodial Hemodialyzer Selectivity Modifications (Evodial +) | Na | End Stage Renal Disease (ESRD) | Completed | 2012-10-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01679483 | Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy fo… | Na | Gynecologic Cancer | Completed | 2012-09-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT01626105 | Personalized Prediction of Tolerance and Immunogenicity in Hemophilia | — | Hemophilia A | Unknown | 2012-06-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01643486 | Development of a 'Phosphate Counting Program' | Na | End Stage Renal Disease | Unknown | 2012-06-01 | 2021-02-01 | ClinicalTrials.gov |
| NCT01602718 | Physical Activity and Functioning in Home Dialysis Patients | Na | Diabetes | Completed | 2012-06-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT01637025 | Oxidized Cellulose hEmostAsis evaluatioN | Na | Intra-operative Bleeding | Completed | 2012-05-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01582867 | HemoControl System Activated in Hemodiafiltration Treatments | Na | Renal Failure | Completed | 2012-05-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01582893 | Permeability Enhancement to Reduce Chronic Inflammation | Na | End Stage Renal Disease | Completed | 2012-04-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01579396 | High Cut Off Dialysis in Systemic Inflammatory Response Syndrome Patients After… | Na | Systemic Inflammatory Response Syndrome | Withdrawn | 2012-04-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01538927 | Effect of Fibrin Sealant on Early Wound Healing | Phase4 | Periodontitis | Completed | 2012-04-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01648777 | Catheter Outcomes With Sternotomy Cardiac Operated | Phase3 | Pneumonia | Completed | 2012-03-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT01526798 | Improvement of EPO-resistance in Hemodialysis Patients With Chronic Inflammatio… | Na | End-Stage Renal Disease (ESRD) | Completed | 2012-03-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01500135 | Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for th… | Phase3 | Bleeding | Completed | 2012-03-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01891461 | Study to Compare the Addition of Floseal to Our Standard of Care to Control Pos… | Phase4 | Intraoperative Bleeding | Completed | 2012-01-01 | 2017-01-01 | ClinicalTrials.gov |
| NCT01513707 | The Effects of Pre-transplant Dialysis Modality on Post-transplant Events | — | Delayed Function of Renal Transplant | Unknown | 2011-12-22 | 2017-12-01 | ClinicalTrials.gov |
| NCT01460056 | e-STEPS: Endotoxin-Associated Sterile Peritonitis Observational Study | — | Endotoxin-associated Sterile Peritonitis | Completed | 2011-12-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01579097 | Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-chamber P… | Phase3 | Nutrition Support | Completed | 2011-12-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01479673 | TICACOS International | Na | Mechanical Ventilation Complication | Unknown | 2011-11-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01545518 | IVIG Treatment for Refractory Immune-Related Adult Epilepsy | Phase2 | Epilepsy, Cryptogenic | Terminated | 2011-11-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01467180 | Myoglobin Removal by High Cut-off CVVHD | Na | Rhabdomyolysis | Completed | 2011-11-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01452022 | Performance of Inductigraft in Spinal Fusion | Na | Degenerative Disk Disease | Completed | 2011-10-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT01457183 | Clinical Evaluation of Bedside Pulse Lavage Irrigation Device | Na | Healthy | Withdrawn | 2011-10-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01410240 | Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty | Phase4 | Knee Replacement Surgery | Completed | 2011-09-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01330433 | Effects of CoSeal on Bleeding & Adhesions in Pediatric Heart Surgery | Phase2 | Congenital Heart Defect | Completed | 2011-08-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT01881776 | Continuous Interscalene Block Results in Superior Recovery Throughout the First… | Early_Phase1 | Postoperative Pain | Completed | 2011-08-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01350440 | Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar … | Phase2 | Spinocerebellar Ataxia | Completed | 2011-08-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01426477 | Veritas in Non-Bridging Ventral Hernia Repair | — | Hernia | Terminated | 2011-08-01 | 2017-08-01 | ClinicalTrials.gov |
| NCT01652027 | Hemophilia Inhibitor Previously Untreated Patient Study | — | Hemophilia A | Completed | 2011-07-01 | 2020-03-01 | ClinicalTrials.gov |
| NCT01413074 | Survival on Peritoneal Dialysis (PD) Versus Hemodialysis (HD) in China | Na | End Stage Renal Disease | Terminated | 2011-06-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01234883 | Intravenous (IV) Solutions for Dehydration in Children With Gastroenteritis | Phase4 | Dehydration | Terminated | 2011-06-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01355757 | Post-Operative Quality of Life Evaluation for Different Anesthesia Techniques f… | Early_Phase1 | Rotator Cuff Injury | Completed | 2011-06-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01206166 | Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically … | Phase3 | Critical Illness | Terminated | 2011-06-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT01310582 | Recovery Following Desflurane Versus Sevoflurane for Outpatient Urologic Surger… | Phase4 | Ureteral Stent Occlusion | Completed | 2011-05-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01404767 | Tight Hemodynamic Control in Patients Who Are Chronically on Metoprolol | Phase4 | Vascular Disease | Terminated | 2011-04-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01363921 | Effect of HCO1100 on Cardiovascular Function | Na | Cardiovascular Disease | Terminated | 2011-04-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01318486 | HepZero:Heparin Free Dialysis With Evodial | Na | Chronic Kidney Disease | Completed | 2011-03-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01181544 | A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis | Na | Renal Failure Chronic Requiring Hemodialysis | Completed | 2011-03-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01277861 | Airway Responses During Desflurane Anesthesia Via a Laryngeal Mask Airway: Effe… | Phase4 | Administration Site Reaction | Completed | 2011-01-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01671228 | Developing and Evaluating the Yorkshire Dialysis Decision Aid | Phase1 | Chronic Kidney Failure | Completed | 2011-01-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01329497 | The Effect of Systemic Dietary Instruction on Management of Plasma Phosphorus L… | Na | Hyperphosphatemia | Unknown | 2011-01-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01204619 | Trial on Education And Clinical Outcomes for Home PD Patients (TEACH) | Na | Risk Reduction | Completed | 2010-12-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT01244321 | COVADIS Pilot Trial: COseal in Ventricular Assist DevIceS | — | End-stage Heart Failure Awaiting VAD Implantation | Unknown | 2010-12-01 | 2018-02-01 | ClinicalTrials.gov |
| NCT01270620 | Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Kn… | Phase4 | Obesity | Completed | 2010-12-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT01020513 | Subcutaneous Recombinant Human Hyaluronidase: Workflow Analysis and Emergency D… | — | Dehydration | Withdrawn | 2010-11-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01244425 | Fibrin Sealant VH S/D 500 S-apr in Hepatic Resection | Phase2 | Bleeding (Oozing) in Hepatic Resection | Completed | 2010-11-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01209273 | Comparison of Quality of Life on Automated Peritoneal Dialysis and Continuous A… | — | End Stage Renal Disease | Completed | 2010-10-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT01454713 | Retrospective Analysis of Veritas in Breast Reconstruction | — | Seroma | Completed | 2010-10-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01219959 | Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuou… | Phase3 | End Stage Renal Disease (ESRD) | Completed | 2010-10-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01242904 | Use of a Bimodal Solution for Peritoneal Dialysis | Phase2 | End Stage Renal Disease | Completed | 2010-09-30 | 2015-02-28 | ClinicalTrials.gov |
| NCT01219881 | Comparing Desflurane to Sevoflurane for the Effect on Recovery Time in Patients… | Phase3 | Cystoscopes | Completed | 2010-09-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01232634 | Validation of Ultrasound as a Diagnostic Tool for Assessment of Hemophilic Arth… | — | Hemophilia | Completed | 2010-09-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01208402 | Esmolol for Treatment of Perioperative Tachycardia | Phase3 | High-risk, Non-cardiovascular Surgeries | Terminated | 2010-09-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01199237 | Impact of Anesthetic Choice (Sevoflurane Versus Desflurane) on Airway Reflex Re… | Phase4 | Airway Reflexes, Protective | Completed | 2010-08-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01112735 | Efficacy and Safety of ARTISS for Flap Adherence in Abdominoplasty | Phase2 | Seroma | Completed | 2010-05-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01116102 | Study of In-line Pressure Using Various Techniques of Subcutaneous Administrati… | Phase4 | Dehydration | Terminated | 2010-05-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT01120431 | Efficacy and Time and Resources for Hylenex-facilitated SC Rehydration Versus O… | Phase4 | Dehydration | Withdrawn | 2010-05-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT01124227 | Peritoneal Dialysis in Congestive Heart Failure | Phase3 | Congestive Heart Failure | Terminated | 2010-04-01 | 2017-09-01 | ClinicalTrials.gov |
| NCT01017159 | Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Dem… | Phase2 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Completed | 2010-04-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01093547 | Open-label, Randomized Trial to Determine the Effect of Icodextrin Versus Dextr… | Phase4 | End Stage Renal Disease | Withdrawn | 2010-02-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01139294 | Descriptive Study of Cardiac Output During Rehydration With Recombinant Human H… | Phase4 | Dehydration | Completed | 2010-02-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT00775034 | Drainage Versus Sealant in Double Blinded Monocentric Open Incisional Hernia Re… | Phase4 | Incisional Hernia | Completed | 2010-01-27 | 2018-05-24 | ClinicalTrials.gov |
| NCT00965198 | Comparison of Infection Rates Among Patients Using Two Catheter Access Devices | — | Catheter-Related Infections | Completed | 2009-11-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01002482 | Computerized Glucose Control in Critically Ill Patients | Phase3 | Hyperglycemia | Completed | 2009-10-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01021878 | Study to Evaluate the Effects Icodextrin Versus Dianeal on Insulin Resistance i… | Phase4 | Disorders Associated With Peritoneal Dialysis | Completed | 2009-10-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT00962000 | Study of How the Dose of Dialysis is Affected by Dialysate Flow Rate | Na | Chronic Kidney Disease | Completed | 2009-09-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00999141 | Efficacy and Safety of FS VH S/D 4 S-apr for Flap Adherence in Rhytidectomy | Phase3 | Face-lift | Completed | 2009-09-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00990509 | Albumin for Intracerebral Hemorrhage Intervention | Phase2 | Intracerebral Hemorrhage | Terminated | 2009-09-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT00958945 | Retrospective Chart Analysis in the Effective Use of FloSeal in Post-Operative … | — | Total Knee Arthroplasty | Unknown | 2009-09-01 | — | ClinicalTrials.gov |
| NCT00974623 | Bone Graft Materials Observational Registry | — | Degenerative Disc Disease | Terminated | 2009-09-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT00892957 | FS VH S/D 500 S-apr in Vascular Surgery | Phase3 | Hemostasis in Participants Receiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft Prostheses | Completed | 2009-07-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01018771 | Actifuse ABX Versus INFUSE in Posterolateral Instrumented Lumbar Fusion | Na | Degenerative Disc Disease | Completed | 2009-07-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00742313 | Effect on Bleeding When Using FloSeal Matrix™ in Subjects Undergoing Endoscopic… | Phase4 | Bleeding | Terminated | 2009-06-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT00922870 | Evaluation of Hemodynamic Effects of Cascade Hemofiltration in Septic Shock | Na | Sepsis | Completed | 2009-04-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT00957255 | Rotator Cuff Repair (RCR) With and Without OrthoADAPT Augmentation | Na | Rotator Cuff Tear | Withdrawn | 2009-03-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00953563 | The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers | Na | Venous Leg Ulcers | Withdrawn | 2009-03-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT00740727 | EASI Access II --- Follow-up Study to the EASI Access Trial | Phase1 | Disaster Medicine | Completed | 2009-02-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00819416 | Fluid Resuscitation in Early Septic Shock | Phase2 | Septic Shock | Completed | 2009-02-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00761475 | Primary Mesh Closure of Abdominal Midline Wounds | Phase3 | Incisional Hernia Occurence | Completed | 2009-02-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT00958711 | The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer | Na | Diabetic Foot Ulcers | Terminated | 2009-01-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT00840437 | Quality of Life in Patients With Refractory Angina | — | Refractory Ischemia | Completed | 2008-12-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00807885 | Study of Techniques of Subcutaneous Administration of Fluids Enabled by Human R… | Phase4 | Dehydration | Completed | 2008-12-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00804453 | Evaluation of the Biocompatibility of Cartridge Blood Set Versus Standard Blood… | Na | Chronic Kidney Failure | Completed | 2008-11-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00672854 | Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in I… | Phase2 | Parenteral Nutrition | Completed | 2008-11-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00773175 | Subcutaneous Rehydration Compared to Intravenous Rehydration | Phase4 | Dehydration | Completed | 2008-10-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00781690 | Reduction of Heparin Dose in Dialysis With Evodial System | Na | Chronic Kidney Failure | Completed | 2008-09-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00962143 | Acute Achilles Repair With or Without OrthADAPT Augmentation | Na | Achilles Tendon Tear | Withdrawn | 2008-06-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT02185729 | Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Li… | Phase2 | Diseases, Metabolic | Completed | 2008-06-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT00708071 | Efficacy and Safety Study of Fibrin Sealant With 4 IU/mL Thrombin, Vapor Heated… | Phase2 | Facial Rhytidectomy (Face-lift) | Completed | 2008-06-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00681824 | Fibrin Sealant for the Sealing of Dura Sutures | Phase2 | Pathological Processes in the Posterior Fossa | Completed | 2008-05-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00649298 | A Clinical Trial of IntensiVE Dialysis | Phase4 | Renal Replacement Therapy | Completed | 2008-05-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT00567398 | IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and A… | Phase3 | ESRD | Completed | 2008-04-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01585311 | Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH) | — | Subarachnoid Hemorrhage (SAH) | Terminated | 2008-03-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT00659724 | Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer | — | Chronic Kidney Failure | Completed | 2008-03-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00762372 | Japan Phase 2/3 Clinical Study With BLM-240 (Desflurane) | Phase2 | Anesthesia | Completed | 2008-02-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00636389 | Molecule Removal and Ease of Use: A Comparison of Two Different Dialyzers | Na | Chronic Kidney Disease | Completed | 2008-02-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00636077 | Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performa… | Na | Chronic Kidney Disease | Completed | 2008-02-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT01304394 | Safety During Use of Paediatric Triple Chamber Bag Formulas | Phase3 | Infant Nutrition Disorders | Completed | 2008-02-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT01258322 | Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients | Na | Peritoneal Dialysis | Completed | 2008-01-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00567489 | IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and A… | Phase4 | ESRD | Completed | 2008-01-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT00547664 | Efficacy of Hylenex in the Treatment of Pain Among Hospice Patients | Na | Pain Management | Completed | 2008-01-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT00616980 | Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia | Phase1 | Peripheral Artery Disease | Completed | 2007-12-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT00576420 | Fibrin Sealant Vascular Surgery Study | Phase2 | Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts) | Completed | 2007-12-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00656370 | Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hyl… | Phase4 | Healthy | Completed | 2007-12-01 | 2008-01-30 | ClinicalTrials.gov |
| NCT00579202 | Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer | — | Hemodialysis | Completed | 2007-10-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00621712 | Clinical Assessment of a New Catheter Surface Coating With Antimicrobial Proper… | Na | Renal Insufficiency | Completed | 2007-10-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00990288 | The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery | Phase4 | Blood Loss | Completed | 2007-10-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT00400790 | Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desfl… | Na | Coronary Artery Bypass | Completed | 2007-09-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00512122 | Impact of Early Parenteral Nutrition Completing Enteral Nutrition in Adult Crit… | Phase4 | Critical Illness | Active_Not_Recruiting | 2007-08-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT00508495 | Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-Containing Solut… | Phase3 | Pain, Postoperative | Completed | 2007-08-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00621114 | Ex Vivo Microbiological Assessment of an Anti-biofilm Catheter in Acute Dialysi… | Na | Hemodialysis | Completed | 2007-08-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00477152 | Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infa… | Phase4 | Dehydration | Completed | 2007-08-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00510549 | Comparison of the Impact of Dialysis Treatment Type on Patient Survival | Phase4 | End Stage Renal Disease | Completed | 2007-07-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT01013389 | Actifuse ABX Versus INFUSE in Posterolateral Instrumented Lumbar Fusion (PLIF) … | Na | Degenerative Disc Disease | Completed | 2007-06-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00493220 | Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous … | Phase1 | Healthy | Completed | 2007-06-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00386386 | Recombinant Hyaluronidase in Out-of-Hospital Setting: The EASI Access Trial | Phase3 | Mass Casualty Incident | Completed | 2007-05-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00890422 | Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Pr… | Phase2 | Tick Borne Encephalitis | Unknown | 2007-03-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00559013 | Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Col… | Na | Colorectal Cancer | Completed | 2007-03-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00649142 | Predisposing Factors for Chronic Postherniotomy Pain | Na | Chronic Postherniotomy Pain | Completed | 2007-01-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00406679 | Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-containing Solut… | Phase3 | Pain, Postoperative | Completed | 2006-11-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00397358 | Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients | Phase4 | Peritoneal Dialysis | Withdrawn | 2006-11-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00368641 | Heart Failure and Peritoneal Ultrafiltration | Phase2 | Congestive Heart Failure | Terminated | 2006-08-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00326560 | Comparison of Glue With Sutures for Pterygium Surgery | Phase3 | Pterygium | Unknown | 2006-05-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00566943 | Reinforcement of Surgical Staple Lines Using Peri-Strips Dry (PSD) With Veritas… | Na | Obesity | Completed | 2006-03-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00306839 | Efficacy Study of Tissucol/Tisseel Fibrin Sealant to Treat Inguinal Hernia | Phase4 | Inguinal Hernia | Completed | 2006-02-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00745225 | Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialy… | Phase4 | End-stage Renal Disease | Completed | 2006-02-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT00418743 | Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC) | — | Small Cell Lung Cancer | Unknown | 2005-12-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT02299466 | Registry for Patients Receiving Intravenous Nutrition at Home | — | Parenteral Nutrition, Home | Recruiting | 2005-12-01 | 2029-12-01 | ClinicalTrials.gov |
| NCT00172211 | Comparison of Oxidative Stress and Insulin Resistance Before and After Using Ph… | Na | Kidney Failure,Chronic | Completed | 2005-09-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00214695 | A Subjective Evaluation of Inflow Pain Associated With the Use of an Experiment… | Na | End Stage Renal Disease | Completed | 2005-05-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00489905 | Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving An… | Na | Prostatic Neoplasms | Completed | 2005-04-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00214721 | A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Per… | Phase3 | End Stage Renal Disease | Completed | 2005-02-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT02424747 | Long-term Survival and Renal Outcomes in Critically Ill Patients After Acute Ki… | — | Acute Kidney Injury | Completed | 2005-01-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00163605 | Performance and Safety of Bone Substitute MBCP-FS in Maxillary Sinus Lift Proce… | Phase2 | Sinus Implant Reconstruction | Completed | 2004-09-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00231582 | High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Progno… | Phase2 | Testicular Neoplasms | Completed | 2004-09-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00205556 | Effect of Increased Convective Clearance by On-Line Hemodiafiltration on All Ca… | Na | End-stage Renal Disease | Completed | 2004-06-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00157131 | Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombi… | Phase3 | Deep Partial or Full Thickness Wounds | Completed | 2004-06-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00875888 | High Cut-Off Continuous Veno-venous Hemodialysis (CVVHD) in Patients Treated fo… | Na | Systemic Inflammatory Response Syndrome | Terminated | 2004-02-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00163592 | Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing V… | — | Femoral Vascular Anastomosis | Completed | 2003-09-01 | 2004-02-01 | ClinicalTrials.gov |
| NCT00614146 | Recompensation of Exacerbated Liver Insufficiency With Hyperbilirubinemia and/o… | Na | Liver Failure | Completed | 2003-04-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00324272 | Post-Operative Drainage Following Lymph Node Dissection | Phase4 | Malignant Melanoma | Completed | 2003-01-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00161733 | Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergen… | Phase3 | Cardiac Surgery Requiring Cardiopulmonary Bypass and Median Sternotomy | Completed | 2002-09-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT00255619 | Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® … | Phase4 | Chronic Renal Failure | Completed | 2002-05-01 | 2004-05-01 | ClinicalTrials.gov |
| NCT01031992 | Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) | Phase3 | Hereditary Hemorrhagic Telangiectasia | Completed | 2002-03-01 | 2002-10-01 | ClinicalTrials.gov |
| NCT00161759 | Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation an… | Phase1 | Burns | Completed | 2002-03-01 | 2004-01-01 | ClinicalTrials.gov |
| NCT00333385 | Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis | Phase4 | Cystic Fibrosis | Terminated | 2001-10-01 | 2004-04-01 | ClinicalTrials.gov |
| NCT00161902 | Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (F… | Phase3 | Hip Replacement Surgery | Completed | 2001-08-01 | 2003-03-01 | ClinicalTrials.gov |
| NCT00161980 | Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (F… | Phase3 | Breast Cancer | Completed | 2001-06-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT00512356 | Efficacy and Safety Study of Anti-Adhesion Product in the Prevention of Intrape… | Phase2 | Intraperitoneal Adhesions | Completed | 2000-12-01 | 2003-04-01 | ClinicalTrials.gov |
| NCT00161915 | Efficacy and Safety of Endoscopic Injection of Fibrin Sealant Versus Endoscopic… | Phase3 | Esophageal and/or Gastric Varices | Completed | 2000-12-01 | 2004-01-01 | ClinicalTrials.gov |
| NCT00287235 | Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Usin… | Na | Hepatic Encephalopathy | Completed | 2000-09-01 | 2004-04-01 | ClinicalTrials.gov |
| NCT02278159 | Evaluation of the Integrated Home Dialysis Model | — | Kidney Failure, Chronic | Completed | 2000-01-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00221845 | Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Ch… | Phase3 | Children | Completed | 1998-01-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT01202708 | Gambro AK200 ULTRA Hemodiafiltration Study | Na | Chronic Renal Failure | Completed | 1997-08-01 | — | ClinicalTrials.gov |
| NCT00007813 | Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients Wit… | Phase1 | Brain and Central Nervous System Tumors | Completed | 1997-05-31 | 2005-02-01 | ClinicalTrials.gov |
Total clinical trials: 327
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| PrisMax System Version 3.x with calcium line accessory | Other | Phase PHASE3 | Regional Citrate Anticoagulation (RCA) | RECRUITING | NCT05399537 |
| Prismocitrate 18 | Other | Phase PHASE3 | Regional Citrate Anticoagulation (RCA) | RECRUITING | NCT05399537 |
| PrisMax System Version 3.x with calcium line accessory | Other | Phase PHASE3 | Regional Citrate Anticoagulation (RCA) | RECRUITING | NCT05399537 |
| Prismocitrate 18 | Other | Phase PHASE3 | Regional Citrate Anticoagulation (RCA) | RECRUITING | NCT05399537 |
| Hypertonic Dextrose solution | Other | Phase PHASE4 | Peritoneal Dialysis | RECRUITING | NCT05721404 |
| Icodextrin Peritoneal Dialysis Solution | Other | Phase PHASE4 | Peritoneal Dialysis | RECRUITING | NCT05721404 |
| Pterygium excision and conjunctival autograft | Other | Phase PHASE3 | Pterygium | UNKNOWN | NCT00326560 |
| Pterygium excision and conjunctival autograft | Other | Phase PHASE3 | Pterygium | UNKNOWN | NCT00326560 |
| Sheet skin grafts affixed with Fibrin Sealant (lyophilized) with 4 IU/mL Thrombin | Other | Phase PHASE1 | Burns | COMPLETED | NCT00161759 |
| Sheet skin grafts affixed with Fibrin Sealant (lyophilized) with 4 IU/mL Thrombin | Other | Phase PHASE1 | Burns | COMPLETED | NCT00161759 |
| Sheet skin grafts affixed with Fibrin Sealant (lyophilized) with 4 IU/mL Thrombin | Other | Phase PHASE1 | Burns | COMPLETED | NCT00161759 |
| Control: Conventional treatment, i.e. compression with swabs | Drug | Preclinical | Femoral Vascular Anastomosis | COMPLETED | NCT00163592 |
| Tissucol® | Other | Preclinical | Femoral Vascular Anastomosis | COMPLETED | NCT00163592 |
| Surgical intervention alone without Fibrin Sealant VH S/D application | Other | Phase PHASE3 | Breast Cancer | COMPLETED | NCT00161980 |
| Fibrin Sealant VH S/D | Other | Phase PHASE3 | Breast Cancer | COMPLETED | NCT00161980 |
| Surgical intervention alone without Fibrin Sealant VH S/D application | Other | Phase PHASE3 | Breast Cancer | COMPLETED | NCT00161980 |
| Fibrin Sealant VH S/D | Other | Phase PHASE3 | Breast Cancer | COMPLETED | NCT00161980 |
| Fibrin Sealant | Other | Phase PHASE3 | Esophageal and/or Gastric Varices | COMPLETED | NCT00161915 |
| Fibrin Sealant Vapor-Heated Solvent/Detergent-treated | Other | Phase PHASE3 | Hip Replacement Surgery | COMPLETED | NCT00161902 |
| Baxter's UltraBag® and FMC Andy·Disc® | Other | Phase PHASE4 | Chronic Renal Failure | COMPLETED | NCT00255619 |
| Baxter's UltraBag® and FMC Andy·Disc® | Other | Phase PHASE4 | Chronic Renal Failure | COMPLETED | NCT00255619 |
| Baxter's UltraBag® and FMC Andy·Disc® | Other | Phase PHASE4 | Chronic Renal Failure | COMPLETED | NCT00255619 |
| Insulin | Other | Phase PHASE1 | Healthy | COMPLETED | NCT00358553 |
| Insulin | Other | Phase PHASE1 | Healthy | COMPLETED | NCT00358553 |
| Macroporous Biphasic Calcium Phosphate-Fibrin Sealant Vapor Heated Solvent/Detergent Treated 4 IU/ML Thrombin (MBCP-FS) | Other | Phase PHASE2 | Sinus Implant Reconstruction | COMPLETED | NCT00163605 |
| Macroporous Biphasic Calcium Phosphate-Fibrin Sealant Vapor Heated Solvent/Detergent Treated 4 IU/ML Thrombin (MBCP-FS) | Other | Phase PHASE2 | Sinus Implant Reconstruction | COMPLETED | NCT00163605 |
| Laparoscopic mesh glue fixation | Other | Approved | Chronic Postherniotomy Pain | COMPLETED | NCT00649142 |
| Open sutured mesh repair | Other | Approved | Chronic Postherniotomy Pain | COMPLETED | NCT00649142 |
| Laparoscopic mesh glue fixation | Other | Approved | Chronic Postherniotomy Pain | COMPLETED | NCT00649142 |
| Open sutured mesh repair | Other | Approved | Chronic Postherniotomy Pain | COMPLETED | NCT00649142 |
| hypodermoclysis via recombinant hyaluronidase-facilitated subcutaneous infusion | Other | Phase PHASE3 | Mass Casualty Incident | COMPLETED | NCT00386386 |
| hypodermoclysis via recombinant hyaluronidase-facilitated subcutaneous infusion | Other | Phase PHASE3 | Mass Casualty Incident | COMPLETED | NCT00386386 |
| Physioneal | Other | Approved | Kidney Failure,Chronic | COMPLETED | NCT00172211 |
| Physioneal | Other | Approved | Kidney Failure,Chronic | COMPLETED | NCT00172211 |
| Modality: Peritoneal Dialysis | Other | Phase PHASE4 | End Stage Renal Disease | COMPLETED | NCT00510549 |
| Modality: Peritoneal Dialysis | Other | Phase PHASE4 | End Stage Renal Disease | COMPLETED | NCT00510549 |
| standardized Lichtenstein technique | Other | Phase PHASE4 | Inguinal Hernia | COMPLETED | NCT00306839 |
| FSME vaccination (FSME-Immun) | Other | Phase PHASE2 | Tick Borne Encephalitis | UNKNOWN | NCT00890422 |
| Enzymatically Augmented Subcutaneous Infusion (EASI) line placement | Other | Phase PHASE1 | Disaster Medicine | COMPLETED | NCT00740727 |
| Human recombinant hyaluronidase (HRH) | Other | Phase PHASE1 | Disaster Medicine | COMPLETED | NCT00740727 |
| Enzymatically Augmented Subcutaneous Infusion (EASI) line placement | Other | Phase PHASE1 | Disaster Medicine | COMPLETED | NCT00740727 |
| Human recombinant hyaluronidase (HRH) | Other | Phase PHASE1 | Disaster Medicine | COMPLETED | NCT00740727 |
| First placebo, than Tranexamic acid. | Other | Phase PHASE3 | Hereditary Hemorrhagic Telangiectasia | COMPLETED | NCT01031992 |
| Tranexamic acid first, than placebo | Other | Phase PHASE3 | Hereditary Hemorrhagic Telangiectasia | COMPLETED | NCT01031992 |
| Add-on Angiotensin Receptor Blockade | Other | Phase PHASE3 | Children | COMPLETED | NCT00221845 |
| Intensified Blood Pressure Control | Other | Phase PHASE3 | Children | COMPLETED | NCT00221845 |
| ACE Inhibition | Other | Phase PHASE3 | Children | COMPLETED | NCT00221845 |
| Add-on Angiotensin Receptor Blockade | Other | Phase PHASE3 | Children | COMPLETED | NCT00221845 |
| Intensified Blood Pressure Control | Other | Phase PHASE3 | Children | COMPLETED | NCT00221845 |
| ACE Inhibition | Other | Phase PHASE3 | Children | COMPLETED | NCT00221845 |
| Normal Saline | Other | Phase PHASE2 | Septic Shock | COMPLETED | NCT00819416 |
| 5% albumin | Other | Phase PHASE2 | Septic Shock | COMPLETED | NCT00819416 |
| Normal Saline | Other | Phase PHASE2 | Septic Shock | COMPLETED | NCT00819416 |
| 5% albumin | Other | Phase PHASE2 | Septic Shock | COMPLETED | NCT00819416 |
| desflurane | Other | Approved | Coronary Artery Bypass | COMPLETED | NCT00400790 |
| propofol | Other | Approved | Coronary Artery Bypass | COMPLETED | NCT00400790 |
| desflurane | Other | Approved | Coronary Artery Bypass | COMPLETED | NCT00400790 |
| propofol | Other | Approved | Coronary Artery Bypass | COMPLETED | NCT00400790 |
| Pioglitazone | Other | Approved | Peritoneal Dialysis | COMPLETED | NCT01258322 |
| Pioglitazone | Other | Approved | Peritoneal Dialysis | COMPLETED | NCT01258322 |
| low flux hemodialysis | Other | Approved | End-stage Renal Disease | COMPLETED | NCT00205556 |
| on-line hemodiafiltration | Other | Approved | End-stage Renal Disease | COMPLETED | NCT00205556 |
| low flux hemodialysis | Other | Approved | End-stage Renal Disease | COMPLETED | NCT00205556 |
| on-line hemodiafiltration | Other | Approved | End-stage Renal Disease | COMPLETED | NCT00205556 |
| low flux hemodialysis | Other | Approved | End-stage Renal Disease | COMPLETED | NCT00205556 |
| on-line hemodiafiltration | Other | Approved | End-stage Renal Disease | COMPLETED | NCT00205556 |
| Ped3CB | Other | Phase PHASE3 | Infant Nutrition Disorders | COMPLETED | NCT01304394 |
| systemic dietary instruction | Other | Approved | Hyperphosphatemia | UNKNOWN | NCT01329497 |
| systemic dietary instruction | Other | Approved | Hyperphosphatemia | UNKNOWN | NCT01329497 |
| Saline and 5% autologous plasma | Other | Phase PHASE1 | Peripheral Artery Disease | COMPLETED | NCT00616980 |
| CD34-positive cells | Other | Phase PHASE1 | Peripheral Artery Disease | COMPLETED | NCT00616980 |
| 0.9% sodium chloride solution | Other | Phase PHASE3 | Pain, Postoperative | COMPLETED | NCT00508495 |
| Paracetamol 1% solution | Other | Phase PHASE3 | Pain, Postoperative | COMPLETED | NCT00508495 |
| Paracetamol (acetaminophen) | Other | Phase PHASE3 | Pain, Postoperative | COMPLETED | NCT00508495 |
| placebo | Other | Phase PHASE3 | Pain, Postoperative | COMPLETED | NCT00406679 |
| paracetamol (acetaminophen) solution commercial | Other | Phase PHASE3 | Pain, Postoperative | COMPLETED | NCT00406679 |
| Paracetamol (acetaminophen) solution experimental | Other | Phase PHASE3 | Pain, Postoperative | COMPLETED | NCT00406679 |
| placebo | Other | Phase PHASE3 | Pain, Postoperative | COMPLETED | NCT00406679 |
| paracetamol (acetaminophen) solution commercial | Other | Phase PHASE3 | Pain, Postoperative | COMPLETED | NCT00406679 |
| Paracetamol (acetaminophen) solution experimental | Other | Phase PHASE3 | Pain, Postoperative | COMPLETED | NCT00406679 |
| Fibrin Sealant (Tisseel) used in the Experimental Arm. | Other | Phase PHASE4 | Malignant Melanoma | COMPLETED | NCT00324272 |
| Fibrin Sealant (Tisseel) used in the Experimental Arm. | Other | Phase PHASE4 | Malignant Melanoma | COMPLETED | NCT00324272 |
| Subcutaneous immunoglobulin | Other | Phase PHASE2 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | COMPLETED | NCT01017159 |
| Subcutaneous immunoglobulin | Other | Phase PHASE2 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | COMPLETED | NCT01017159 |
| FS VH S/D 4 s-apr | Other | Phase PHASE3 | Face-lift | COMPLETED | NCT00999141 |
| FS VH S/D 4 s-apr | Other | Phase PHASE3 | Face-lift | COMPLETED | NCT00999141 |
| FS VH S/D 4 s-apr | Other | Phase PHASE3 | Face-lift | COMPLETED | NCT00999141 |
| Fibrin Sealant with 4 IU/ml Thrombin, Vapor-Heated, Solvent Detergent Treated Containing Synthetic Aprotinin (FS VH S/D 4) | Other | Phase PHASE2 | Facial Rhytidectomy (Face-lift) | COMPLETED | NCT00708071 |
| Fibrin Sealant with 4 IU/ml Thrombin, Vapor-Heated, Solvent Detergent Treated Containing Synthetic Aprotinin (FS VH S/D 4) | Other | Phase PHASE2 | Facial Rhytidectomy (Face-lift) | COMPLETED | NCT00708071 |
| Desflurane | Other | Phase PHASE4 | Patients Undergoing Elective Craniotomy | UNKNOWN | NCT01985854 |
| Propofol | Other | Phase PHASE4 | Patients Undergoing Elective Craniotomy | UNKNOWN | NCT01985854 |
| Desflurane | Other | Phase PHASE4 | Patients Undergoing Elective Craniotomy | UNKNOWN | NCT01985854 |
| Propofol | Other | Phase PHASE4 | Patients Undergoing Elective Craniotomy | UNKNOWN | NCT01985854 |
| Surgical gauze pads | Other | Phase PHASE3 | Hemostasis in Participants Receiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft Prostheses | COMPLETED | NCT00892957 |
| Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/ml thrombin and synthetic aprotinin (FS VH S/D 500 s-apr) | Other | Phase PHASE3 | Hemostasis in Participants Receiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft Prostheses | COMPLETED | NCT00892957 |
| Surgical gauze pads | Other | Phase PHASE3 | Hemostasis in Participants Receiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft Prostheses | COMPLETED | NCT00892957 |
| Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/ml thrombin and synthetic aprotinin (FS VH S/D 500 s-apr) | Other | Phase PHASE3 | Hemostasis in Participants Receiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft Prostheses | COMPLETED | NCT00892957 |
| Manual compression with surgical gauze pads | Other | Phase PHASE2 | Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts) | COMPLETED | NCT00576420 |
| FS VH S/D 500 s-apr, 120-seconds polymerization time | Other | Phase PHASE2 | Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts) | COMPLETED | NCT00576420 |
| FS VH S/D 500 s-apr, 60-seconds polymerization time | Other | Phase PHASE2 | Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts) | COMPLETED | NCT00576420 |
| Manual compression with surgical gauze pads | Other | Phase PHASE2 | Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts) | COMPLETED | NCT00576420 |
| FS VH S/D 500 s-apr, 120-seconds polymerization time | Other | Phase PHASE2 | Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts) | COMPLETED | NCT00576420 |
| FS VH S/D 500 s-apr, 60-seconds polymerization time | Other | Phase PHASE2 | Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts) | COMPLETED | NCT00576420 |
| Manual compression with surgical gauze pads | Other | Phase PHASE2 | Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts) | COMPLETED | NCT00576420 |
| FS VH S/D 500 s-apr, 120-seconds polymerization time | Other | Phase PHASE2 | Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts) | COMPLETED | NCT00576420 |
| FS VH S/D 500 s-apr, 60-seconds polymerization time | Other | Phase PHASE2 | Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts) | COMPLETED | NCT00576420 |
| Suture | Other | Phase PHASE4 | Periodontitis | COMPLETED | NCT01538927 |
| Fibrin Sealant | Other | Phase PHASE4 | Periodontitis | COMPLETED | NCT01538927 |
| Suture | Other | Phase PHASE4 | Periodontitis | COMPLETED | NCT01538927 |
| Fibrin Sealant | Other | Phase PHASE4 | Periodontitis | COMPLETED | NCT01538927 |
| Suture | Other | Phase PHASE4 | Periodontitis | COMPLETED | NCT01538927 |
| Fibrin Sealant | Other | Phase PHASE4 | Periodontitis | COMPLETED | NCT01538927 |
| Parenteral Nutrition | Other | Preclinical | Other Preterm Infants | UNKNOWN | NCT01772927 |
| Parenteral Nutrition | Other | Preclinical | Other Preterm Infants | UNKNOWN | NCT01772927 |
| Parenteral Nutrition | Other | Preclinical | Other Preterm Infants | UNKNOWN | NCT01772927 |
| Compounded ternary parenteral nutrition admixtures | Other | Phase PHASE3 | Nutrition Support | COMPLETED | NCT01579097 |
| Oliclinomel N4 | Other | Phase PHASE3 | Nutrition Support | COMPLETED | NCT01579097 |
| Compounded ternary parenteral nutrition admixtures | Other | Phase PHASE3 | Nutrition Support | COMPLETED | NCT01579097 |
| Oliclinomel N4 | Other | Phase PHASE3 | Nutrition Support | COMPLETED | NCT01579097 |
| Compounded ternary parenteral nutrition admixtures | Other | Phase PHASE3 | Nutrition Support | COMPLETED | NCT01579097 |
| Oliclinomel N4 | Other | Phase PHASE3 | Nutrition Support | COMPLETED | NCT01579097 |
| Fentanyl | Other | Phase PHASE4 | Administration Site Reaction | COMPLETED | NCT01277861 |
| Fentanyl | Other | Phase PHASE4 | Administration Site Reaction | COMPLETED | NCT01277861 |
| Standard of care | Other | Phase PHASE2 | Pathological Processes in the Posterior Fossa | COMPLETED | NCT00681824 |
| Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/mL thrombin and synthetic aprotinin (FS VH S/D 500 s-apr) | Other | Phase PHASE2 | Pathological Processes in the Posterior Fossa | COMPLETED | NCT00681824 |
| Standard of care | Other | Phase PHASE2 | Pathological Processes in the Posterior Fossa | COMPLETED | NCT00681824 |
| Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/mL thrombin and synthetic aprotinin (FS VH S/D 500 s-apr) | Other | Phase PHASE2 | Pathological Processes in the Posterior Fossa | COMPLETED | NCT00681824 |
| Standard of care | Other | Phase PHASE2 | Pathological Processes in the Posterior Fossa | COMPLETED | NCT00681824 |
| Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/mL thrombin and synthetic aprotinin (FS VH S/D 500 s-apr) | Other | Phase PHASE2 | Pathological Processes in the Posterior Fossa | COMPLETED | NCT00681824 |
| IVIG | Other | Phase PHASE2 | Spinocerebellar Ataxia | COMPLETED | NCT01350440 |
| IVIG | Other | Phase PHASE2 | Spinocerebellar Ataxia | COMPLETED | NCT01350440 |
| Zolderonic acid (Zometa) | Other | Approved | Prostatic Neoplasms | COMPLETED | NCT00489905 |
| Zolderonic acid (Zometa) | Other | Approved | Prostatic Neoplasms | COMPLETED | NCT00489905 |
| Indirect Calorimetry measurement of Resting Energy Expenditure . | Other | Approved | Mechanical Ventilation Complication | UNKNOWN | NCT01479673 |
| Standard-Care Glucose Control | Other | Phase PHASE3 | Hyperglycemia | COMPLETED | NCT01002482 |
| CGAO-based Glucose Control | Other | Phase PHASE3 | Hyperglycemia | COMPLETED | NCT01002482 |
| Desflurane | Other | Phase PHASE4 | Aortic Valve Stenosis | UNKNOWN | NCT02019797 |
| Sevoflurane | Other | Phase PHASE4 | Ureteral Stent Occlusion | COMPLETED | NCT01310582 |
| Desflurane | Other | Phase PHASE4 | Ureteral Stent Occlusion | COMPLETED | NCT01310582 |
| Sevoflurane | Other | Phase PHASE4 | Ureteral Stent Occlusion | COMPLETED | NCT01310582 |
| Desflurane | Other | Phase PHASE4 | Ureteral Stent Occlusion | COMPLETED | NCT01310582 |
| Saline | Other | Approved | Pain Management | COMPLETED | NCT00547664 |
| Hylenex recombinant , morphine, saline | Other | Approved | Pain Management | COMPLETED | NCT00547664 |
| FloSeal Matrix | Other | Phase PHASE4 | Bleeding | TERMINATED | NCT00742313 |
| FloSeal Matrix | Other | Phase PHASE4 | Bleeding | TERMINATED | NCT00742313 |
| FloSeal Matrix | Other | Phase PHASE4 | Bleeding | TERMINATED | NCT00742313 |
| Glycopyrrolate | Other | Phase PHASE4 | Airway Reflexes, Protective | COMPLETED | NCT01199237 |
| Neostigmine | Other | Phase PHASE4 | Airway Reflexes, Protective | COMPLETED | NCT01199237 |
| Rocuronium | Other | Phase PHASE4 | Airway Reflexes, Protective | COMPLETED | NCT01199237 |
| Desflurane | Other | Phase PHASE4 | Airway Reflexes, Protective | COMPLETED | NCT01199237 |
| Sevoflurane | Other | Phase PHASE4 | Airway Reflexes, Protective | COMPLETED | NCT01199237 |
| Glycopyrrolate | Other | Phase PHASE4 | Airway Reflexes, Protective | COMPLETED | NCT01199237 |
| Neostigmine | Other | Phase PHASE4 | Airway Reflexes, Protective | COMPLETED | NCT01199237 |
| Rocuronium | Other | Phase PHASE4 | Airway Reflexes, Protective | COMPLETED | NCT01199237 |
| Desflurane | Other | Phase PHASE4 | Airway Reflexes, Protective | COMPLETED | NCT01199237 |
| Sevoflurane | Other | Phase PHASE4 | Airway Reflexes, Protective | COMPLETED | NCT01199237 |
| Glycopyrrolate | Other | Phase PHASE4 | Airway Reflexes, Protective | COMPLETED | NCT01199237 |
| Neostigmine | Other | Phase PHASE4 | Airway Reflexes, Protective | COMPLETED | NCT01199237 |
| Rocuronium | Other | Phase PHASE4 | Airway Reflexes, Protective | COMPLETED | NCT01199237 |
| Desflurane | Other | Phase PHASE4 | Airway Reflexes, Protective | COMPLETED | NCT01199237 |
| Sevoflurane | Other | Phase PHASE4 | Airway Reflexes, Protective | COMPLETED | NCT01199237 |
| Single Injection of Local Anesthetic | Other | Phase EARLY_PHASE1 | Rotator Cuff Injury | COMPLETED | NCT01355757 |
| Baxter INFUSOR System | Other | Phase EARLY_PHASE1 | Rotator Cuff Injury | COMPLETED | NCT01355757 |
| Single Injection of Local Anesthetic | Other | Phase EARLY_PHASE1 | Rotator Cuff Injury | COMPLETED | NCT01355757 |
| Baxter INFUSOR System | Other | Phase EARLY_PHASE1 | Rotator Cuff Injury | COMPLETED | NCT01355757 |
| ISB | Other | Phase EARLY_PHASE1 | Postoperative Pain | COMPLETED | NCT01881776 |
| ISB | Other | Phase EARLY_PHASE1 | Postoperative Pain | COMPLETED | NCT01881776 |
| FLOSEAL Hemostatic Matrix + Standard of care | Other | Phase PHASE4 | Knee Replacement Surgery | COMPLETED | NCT01410240 |
| Standard of Care | Other | Phase PHASE4 | Knee Replacement Surgery | COMPLETED | NCT01410240 |
| FLOSEAL Hemostatic Matrix + Standard of care | Other | Phase PHASE4 | Knee Replacement Surgery | COMPLETED | NCT01410240 |
| Standard of Care | Other | Phase PHASE4 | Knee Replacement Surgery | COMPLETED | NCT01410240 |
| FLOSEAL Hemostatic Matrix + Standard of care | Other | Phase PHASE4 | Knee Replacement Surgery | COMPLETED | NCT01410240 |
| Standard of Care | Other | Phase PHASE4 | Knee Replacement Surgery | COMPLETED | NCT01410240 |
| blank control | Other | Approved | Chronic Renal Disease | UNKNOWN | NCT02190318 |
| spirolactone | Other | Approved | Chronic Renal Disease | UNKNOWN | NCT02190318 |
| Losartan | Other | Approved | Chronic Renal Disease | UNKNOWN | NCT02190318 |
| blank control | Other | Approved | Chronic Renal Disease | UNKNOWN | NCT02190318 |
| spirolactone | Other | Approved | Chronic Renal Disease | UNKNOWN | NCT02190318 |
| Losartan | Other | Approved | Chronic Renal Disease | UNKNOWN | NCT02190318 |
| Brain MRI with and without contrast | Other | Phase PHASE2 | Intracerebral Hemorrhage | TERMINATED | NCT00990509 |
| Placebo | Other | Phase PHASE2 | Intracerebral Hemorrhage | TERMINATED | NCT00990509 |
| Albumin | Other | Phase PHASE2 | Intracerebral Hemorrhage | TERMINATED | NCT00990509 |
| Brain MRI with and without contrast | Other | Phase PHASE2 | Intracerebral Hemorrhage | TERMINATED | NCT00990509 |
| Placebo | Other | Phase PHASE2 | Intracerebral Hemorrhage | TERMINATED | NCT00990509 |
| Albumin | Other | Phase PHASE2 | Intracerebral Hemorrhage | TERMINATED | NCT00990509 |
| IVIG | Other | Phase PHASE2 | Epilepsy, Cryptogenic | TERMINATED | NCT01545518 |
| IVIG | Other | Phase PHASE2 | Epilepsy, Cryptogenic | TERMINATED | NCT01545518 |
| CoSeal spray | Other | Preclinical | Biliary Atresia | UNKNOWN | NCT01745991 |
| CoSeal spray | Other | Preclinical | Biliary Atresia | UNKNOWN | NCT01745991 |
| CoSeal spray | Other | Preclinical | Biliary Atresia | UNKNOWN | NCT01745991 |
| Dianeal | Other | Phase PHASE4 | Disorders Associated With Peritoneal Dialysis | COMPLETED | NCT01021878 |
| icodextrin | Other | Phase PHASE4 | Disorders Associated With Peritoneal Dialysis | COMPLETED | NCT01021878 |
| Dianeal | Other | Phase PHASE4 | Disorders Associated With Peritoneal Dialysis | COMPLETED | NCT01021878 |
| icodextrin | Other | Phase PHASE4 | Disorders Associated With Peritoneal Dialysis | COMPLETED | NCT01021878 |
| CoVa | Other | Preclinical | Congestive Heart Failure | COMPLETED | NCT02252757 |
| CoVa | Other | Preclinical | Congestive Heart Failure | COMPLETED | NCT02252757 |
| Esmolol | Other | Phase PHASE3 | High-risk, Non-cardiovascular Surgeries | TERMINATED | NCT01208402 |
| primary closure | Other | Phase PHASE3 | Incisional Hernia Occurence | COMPLETED | NCT00761475 |
| mesh supported closure | Other | Phase PHASE3 | Incisional Hernia Occurence | COMPLETED | NCT00761475 |
| primary closure | Other | Phase PHASE3 | Incisional Hernia Occurence | COMPLETED | NCT00761475 |
| mesh supported closure | Other | Phase PHASE3 | Incisional Hernia Occurence | COMPLETED | NCT00761475 |
| 15% CLINISOL - Sulfite-free (Amino Acid) Injection | Other | Phase PHASE4 | Parenteral Nutrition (No Primary Condition Studied) | TERMINATED | NCT01923480 |
| 15% CLINISOL - Sulfite-free (Amino Acid) Injection | Other | Phase PHASE4 | Parenteral Nutrition (No Primary Condition Studied) | TERMINATED | NCT01923480 |
| INFUSE, plus master granules (MGG) | Other | Approved | Degenerative Disc Disease | COMPLETED | NCT01013389 |
| Actifuse ABX | Other | Approved | Degenerative Disc Disease | COMPLETED | NCT01013389 |
| INFUSE, plus master granules (MGG) | Other | Approved | Degenerative Disc Disease | COMPLETED | NCT01013389 |
| Actifuse ABX | Other | Approved | Degenerative Disc Disease | COMPLETED | NCT01013389 |
| Bone graft substitute, autograft or allograft | Other | Preclinical | Degenerative Disc Disease | TERMINATED | NCT00974623 |
| PD treatment | Drug | Approved | Disorders Associated With Peritoneal Dialysis | UNKNOWN | NCT02646436 |
| HD treatment | Drug | Approved | Disorders Associated With Peritoneal Dialysis | UNKNOWN | NCT02646436 |
| Oxiris | Other | Preclinical | Acute Kidney Injury | COMPLETED | NCT04952714 |
| Home hemodialysis | Other | Preclinical | Kidney Failure, Chronic | COMPLETED | NCT02278159 |
| Peritoneal dialysis | Other | Preclinical | Kidney Failure, Chronic | COMPLETED | NCT02278159 |
| Home hemodialysis | Other | Preclinical | Kidney Failure, Chronic | COMPLETED | NCT02278159 |
| Peritoneal dialysis | Other | Preclinical | Kidney Failure, Chronic | COMPLETED | NCT02278159 |
| Saline (control) | Other | Phase PHASE2 | Diseases, Metabolic | COMPLETED | NCT02185729 |
| Dextrose | Other | Phase PHASE2 | Diseases, Metabolic | COMPLETED | NCT02185729 |
| ClinOleic | Other | Phase PHASE2 | Diseases, Metabolic | COMPLETED | NCT02185729 |
| Intralipid | Other | Phase PHASE2 | Diseases, Metabolic | COMPLETED | NCT02185729 |
| Floseal | Other | Phase PHASE3 | Gynecologic Cancer | UNKNOWN | NCT01974193 |
| Metoprolol | Other | Phase PHASE4 | Vascular Disease | TERMINATED | NCT01404767 |
| Esmolol | Other | Phase PHASE4 | Vascular Disease | TERMINATED | NCT01404767 |
| Metoprolol | Other | Phase PHASE4 | Vascular Disease | TERMINATED | NCT01404767 |
| Esmolol | Other | Phase PHASE4 | Vascular Disease | TERMINATED | NCT01404767 |
| Acute Kidney Injury | Other | Preclinical | Acute Kidney Injury | COMPLETED | NCT02424747 |
| Acute Kidney Injury | Other | Preclinical | Acute Kidney Injury | COMPLETED | NCT02424747 |
| placebo | Other | Phase PHASE3 | Pneumonia | COMPLETED | NCT01648777 |
| L bupivacaine | Other | Phase PHASE3 | Pneumonia | COMPLETED | NCT01648777 |
| placebo | Other | Phase PHASE3 | Pneumonia | COMPLETED | NCT01648777 |
| L bupivacaine | Other | Phase PHASE3 | Pneumonia | COMPLETED | NCT01648777 |
| placebo | Other | Phase PHASE3 | Pneumonia | COMPLETED | NCT01648777 |
| L bupivacaine | Other | Phase PHASE3 | Pneumonia | COMPLETED | NCT01648777 |
| Desflurane | Other | Phase PHASE4 | Obesity | COMPLETED | NCT01270620 |
| propofol | Other | Phase PHASE4 | Obesity | COMPLETED | NCT01270620 |
| Desflurane | Other | Phase PHASE4 | Obesity | COMPLETED | NCT01270620 |
| propofol | Other | Phase PHASE4 | Obesity | COMPLETED | NCT01270620 |
| Desflurane | Other | Phase PHASE4 | Obesity | COMPLETED | NCT01270620 |
| propofol | Other | Phase PHASE4 | Obesity | COMPLETED | NCT01270620 |
| Esmolol | Other | Phase PHASE2 | Septic Shock | UNKNOWN | NCT02068287 |
| Esmolol | Other | Phase PHASE2 | Septic Shock | UNKNOWN | NCT02068287 |
| Short daily dialysis for 2 weeks | Other | Approved | Hemodialysis | COMPLETED | NCT01975025 |
| Intensive training group | Other | Approved | Risk Reduction | COMPLETED | NCT01204619 |
| Intensive training group | Other | Approved | Risk Reduction | COMPLETED | NCT01204619 |
| Sympton Assessment | Other | Approved | End Stage Renal Disease | COMPLETED | NCT01912001 |
| Telephone follow-up | Other | Approved | End Stage Renal Disease | COMPLETED | NCT01912001 |
| Intravenous Immune Globulin (IVIG) | Other | Phase PHASE1 | Spinocerebellar Ataxias | UNKNOWN | NCT02287064 |
| Standard Care | Other | Phase PHASE2 | Multiple Organ Failure | COMPLETED | NCT01847534 |
| Supplemental PN | Other | Phase PHASE2 | Multiple Organ Failure | COMPLETED | NCT01847534 |
| Standard Care | Other | Phase PHASE2 | Multiple Organ Failure | COMPLETED | NCT01847534 |
| Supplemental PN | Other | Phase PHASE2 | Multiple Organ Failure | COMPLETED | NCT01847534 |
| Glucion 5% | Other | Phase PHASE4 | Healthy Adult Volunteers | COMPLETED | NCT02822898 |
| NaCl 0.9% in Glucose 5% with 40mEq Potassium | Other | Phase PHASE4 | Healthy Adult Volunteers | COMPLETED | NCT02822898 |
| Glucion 5% | Other | Phase PHASE4 | Healthy Adult Volunteers | COMPLETED | NCT02822898 |
| NaCl 0.9% in Glucose 5% with 40mEq Potassium | Other | Phase PHASE4 | Healthy Adult Volunteers | COMPLETED | NCT02822898 |
| exercise training | Other | Approved | Diabetes | COMPLETED | NCT01602718 |
| exercise training | Other | Approved | Diabetes | COMPLETED | NCT01602718 |
| CoSeal Surgical Spray Group | Other | Phase PHASE2 | Congenital Heart Defect | COMPLETED | NCT01330433 |
| Inductigraft | Other | Approved | Degenerative Disk Disease | COMPLETED | NCT01452022 |
| Inductigraft | Other | Approved | Degenerative Disk Disease | COMPLETED | NCT01452022 |
| INFUSE, plus Mastergraft granules | Other | Approved | Degenerative Disc Disease | COMPLETED | NCT01018771 |
| Actifuse ABX | Other | Approved | Degenerative Disc Disease | COMPLETED | NCT01018771 |
| INFUSE, plus Mastergraft granules | Other | Approved | Degenerative Disc Disease | COMPLETED | NCT01018771 |
| Actifuse ABX | Other | Approved | Degenerative Disc Disease | COMPLETED | NCT01018771 |
| INFUSE, plus master granules (MGG) | Other | Approved | Degenerative Disc Disease | COMPLETED | NCT01013389 |
| Actifuse ABX | Other | Approved | Degenerative Disc Disease | COMPLETED | NCT01013389 |
| TISSEEL VH fibrin sealant | Other | Phase PHASE3 | Cardiac Surgery Requiring Cardiopulmonary Bypass and Median Sternotomy | COMPLETED | NCT00161733 |
| Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) | Other | Phase PHASE3 | Cardiac Surgery Requiring Cardiopulmonary Bypass and Median Sternotomy | COMPLETED | NCT00161733 |
| TISSEEL VH fibrin sealant | Other | Phase PHASE3 | Cardiac Surgery Requiring Cardiopulmonary Bypass and Median Sternotomy | COMPLETED | NCT00161733 |
| Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) | Other | Phase PHASE3 | Cardiac Surgery Requiring Cardiopulmonary Bypass and Median Sternotomy | COMPLETED | NCT00161733 |
| Staples | Other | Phase PHASE3 | Deep Partial or Full Thickness Wounds | COMPLETED | NCT00157131 |
| Fibrin Sealant, ARTISS 4IU/ml VH SD | Other | Phase PHASE3 | Deep Partial or Full Thickness Wounds | COMPLETED | NCT00157131 |
| Staples | Other | Phase PHASE3 | Deep Partial or Full Thickness Wounds | COMPLETED | NCT00157131 |
| Fibrin Sealant, ARTISS 4IU/ml VH SD | Other | Phase PHASE3 | Deep Partial or Full Thickness Wounds | COMPLETED | NCT00157131 |
| Multilevel Spinal fusion with Actifuse ABX® | Other | Phase PHASE4 | Scoliosis | TERMINATED | NCT01852747 |
| FloSeal application | Other | Approved | Gynecologic Cancer | COMPLETED | NCT01679483 |
| FloSeal application | Other | Approved | Gynecologic Cancer | COMPLETED | NCT01679483 |
| FloSeal application | Other | Approved | Gynecologic Cancer | COMPLETED | NCT01679483 |
| Anti-Adhesion Product | Other | Phase PHASE2 | Intraperitoneal Adhesions | COMPLETED | NCT00512356 |
| Floseal | Other | Phase PHASE4 | Intraoperative Bleeding | COMPLETED | NCT01891461 |
| Floseal | Other | Phase PHASE4 | Intraoperative Bleeding | COMPLETED | NCT01891461 |
| Vivia Home Hemodialysis System | Other | Preclinical | Renal Failure Chronic Requiring Hemodialysis | UNKNOWN | NCT02583347 |
| icodextrin | Other | Phase PHASE2 | End Stage Renal Disease | COMPLETED | NCT01242904 |
| bimodal solution | Other | Phase PHASE2 | End Stage Renal Disease | COMPLETED | NCT01242904 |
| icodextrin | Other | Phase PHASE2 | End Stage Renal Disease | COMPLETED | NCT01242904 |
| bimodal solution | Other | Phase PHASE2 | End Stage Renal Disease | COMPLETED | NCT01242904 |
| icodextrin | Other | Phase PHASE2 | End Stage Renal Disease | COMPLETED | NCT01242904 |
| bimodal solution | Other | Phase PHASE2 | End Stage Renal Disease | COMPLETED | NCT01242904 |
| Parenteral nutrition | Other | Approved | Gastrointestinal Cancer | TERMINATED | NCT02066363 |
| Dietician advise | Other | Approved | Gastrointestinal Cancer | TERMINATED | NCT02066363 |
| Parenteral nutrition | Other | Approved | Gastrointestinal Cancer | TERMINATED | NCT02066363 |
| Dietician advise | Other | Approved | Gastrointestinal Cancer | TERMINATED | NCT02066363 |
| Parenteral nutrition | Other | Approved | Gastrointestinal Cancer | TERMINATED | NCT02066363 |
| Dietician advise | Other | Approved | Gastrointestinal Cancer | TERMINATED | NCT02066363 |
| Citrate dialysate | Other | Approved | Hemodialysis-Induced Symptom | UNKNOWN | NCT03319680 |
| Citrate dialysate | Other | Approved | Hemodialysis-Induced Symptom | UNKNOWN | NCT03319680 |
| Common Surgical Techniques | Other | Approved | Hepatectomy | UNKNOWN | NCT03323359 |
| Hemopatch | Other | Approved | Hepatectomy | UNKNOWN | NCT03323359 |
| Common Surgical Techniques | Other | Approved | Hepatectomy | UNKNOWN | NCT03323359 |
| Hemopatch | Other | Approved | Hepatectomy | UNKNOWN | NCT03323359 |
| Hemostatic Matrix | Other | Phase PHASE4 | Blood Loss | COMPLETED | NCT00990288 |
| Hemostatic Matrix | Other | Phase PHASE4 | Blood Loss | COMPLETED | NCT00990288 |
| Hemostatic Matrix | Other | Phase PHASE4 | Blood Loss | COMPLETED | NCT00990288 |
| Hylenex | Other | Phase PHASE4 | Dehydration | COMPLETED | NCT01139294 |
| Hylenex | Other | Phase PHASE4 | Dehydration | COMPLETED | NCT01139294 |
| saline | Other | Phase PHASE4 | Dehydration | TERMINATED | NCT01234883 |
| multiple electrolyte solution | Other | Phase PHASE4 | Dehydration | TERMINATED | NCT01234883 |
| Subcuvia | Other | Phase PHASE2 | Multifocal Motor Neuropathy | COMPLETED | NCT02556437 |
| HyQvia | Other | Phase PHASE2 | Multifocal Motor Neuropathy | COMPLETED | NCT02556437 |
| Subcuvia | Other | Phase PHASE2 | Multifocal Motor Neuropathy | COMPLETED | NCT02556437 |
| HyQvia | Other | Phase PHASE2 | Multifocal Motor Neuropathy | COMPLETED | NCT02556437 |
| Drainage | Other | Phase PHASE4 | Incisional Hernia | COMPLETED | NCT00775034 |
| Tisseel® | Other | Phase PHASE4 | Incisional Hernia | COMPLETED | NCT00775034 |
| Drainage | Other | Phase PHASE4 | Incisional Hernia | COMPLETED | NCT00775034 |
| Tisseel® | Other | Phase PHASE4 | Incisional Hernia | COMPLETED | NCT00775034 |
| Standard of care | Other | Phase PHASE2 | Seroma | COMPLETED | NCT01112735 |
| FS VH S/D 4 s-apr (= two-component fibrin sealant, double virus inactivated, made from pooled human plasma) | Other | Phase PHASE2 | Seroma | COMPLETED | NCT01112735 |
| Standard of care | Other | Phase PHASE2 | Seroma | COMPLETED | NCT01112735 |
| FS VH S/D 4 s-apr (= two-component fibrin sealant, double virus inactivated, made from pooled human plasma) | Other | Phase PHASE2 | Seroma | COMPLETED | NCT01112735 |
| Intralipid, 20% Intravenous Emulsion | Other | Phase PHASE2 | Parenteral Nutrition | COMPLETED | NCT00672854 |
| ClinOleic 20% Intravenous Emulsion | Other | Phase PHASE2 | Parenteral Nutrition | COMPLETED | NCT00672854 |
| Intralipid, 20% Intravenous Emulsion | Other | Phase PHASE2 | Parenteral Nutrition | COMPLETED | NCT00672854 |
| ClinOleic 20% Intravenous Emulsion | Other | Phase PHASE2 | Parenteral Nutrition | COMPLETED | NCT00672854 |
| sevoflurane/nitrous oxide | Other | Phase PHASE2 | Anesthesia | COMPLETED | NCT00762372 |
| desflurane/nitrous oxide | Other | Phase PHASE2 | Anesthesia | COMPLETED | NCT00762372 |
| desflurane | Other | Phase PHASE2 | Anesthesia | COMPLETED | NCT00762372 |
| sevoflurane/nitrous oxide | Other | Phase PHASE2 | Anesthesia | COMPLETED | NCT00762372 |
| desflurane/nitrous oxide | Other | Phase PHASE2 | Anesthesia | COMPLETED | NCT00762372 |
| desflurane | Other | Phase PHASE2 | Anesthesia | COMPLETED | NCT00762372 |
| oXiris filter | Other | Preclinical | Sepsis | UNKNOWN | NCT03914586 |
| oXiris filter | Other | Preclinical | Sepsis | UNKNOWN | NCT03914586 |
| Glucose solution | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02166359 |
| Extraneal (Icodextrin) | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02166359 |
| Glucose solution | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02166359 |
| Extraneal (Icodextrin) | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02166359 |
| Other | Approved | Dietary Modification | COMPLETED | NCT02426580 | |
| On-Line Haemodiafiltration | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03510520 |
| Medium Cut-Off Haemodialysis | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03510520 |
| On-Line Haemodiafiltration | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03510520 |
| Medium Cut-Off Haemodialysis | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03510520 |
| Medical Device Hemopatch-PEG-coated collagen patch | Device | Approved | CHD - Coronary Heart Disease | UNKNOWN | NCT03340090 |
| Medical Device Hemopatch-PEG-coated collagen patch | Device | Approved | CHD - Coronary Heart Disease | UNKNOWN | NCT03340090 |
| ClinOleic (Baxter Healthcare, Deerfield, IL, USA) | Other | Phase PHASE1 | Nutritional Supplement Toxicity | UNKNOWN | NCT04051840 |
| ClinOleic (Baxter Healthcare, Deerfield, IL, USA) | Other | Phase PHASE1 | Nutritional Supplement Toxicity | UNKNOWN | NCT04051840 |
| icodextrin | Other | Phase PHASE3 | Congestive Heart Failure | TERMINATED | NCT01124227 |
| icodextrin | Other | Phase PHASE3 | Congestive Heart Failure | TERMINATED | NCT01124227 |
| Discontinuation of using device | Device | Preclinical | CHF | COMPLETED | NCT03207802 |
| DuraSeal Dural Sealant | Other | Phase PHASE3 | Cerebrospinal Fluid Leak | COMPLETED | NCT02891070 |
| FS VH S/D 500 s-apr | Other | Phase PHASE3 | Cerebrospinal Fluid Leak | COMPLETED | NCT02891070 |
| DuraSeal Dural Sealant | Other | Phase PHASE3 | Cerebrospinal Fluid Leak | COMPLETED | NCT02891070 |
| FS VH S/D 500 s-apr | Other | Phase PHASE3 | Cerebrospinal Fluid Leak | COMPLETED | NCT02891070 |
| DuraSeal Dural Sealant | Other | Phase PHASE3 | Cerebrospinal Fluid Leak | COMPLETED | NCT02891070 |
| FS VH S/D 500 s-apr | Other | Phase PHASE3 | Cerebrospinal Fluid Leak | COMPLETED | NCT02891070 |
| Numeta G13 | Other | Preclinical | Weight Gain | UNKNOWN | NCT04168749 |
| Numeta G13 | Other | Preclinical | Weight Gain | UNKNOWN | NCT04168749 |
| haemodialysis | Other | Phase PHASE4 | Renal Replacement Therapy | COMPLETED | NCT00649298 |
| haemodialysis | Other | Phase PHASE4 | Renal Replacement Therapy | COMPLETED | NCT00649298 |
| Manual compression with surgical gauze pads | Other | Phase PHASE3 | Adjunct to Hemostasis During Vascular Surgery | COMPLETED | NCT04083807 |
| TISSEEL Lyo | Other | Phase PHASE3 | Adjunct to Hemostasis During Vascular Surgery | COMPLETED | NCT04083807 |
| Manual compression with surgical gauze pads | Other | Phase PHASE3 | Adjunct to Hemostasis During Vascular Surgery | COMPLETED | NCT04083807 |
| TISSEEL Lyo | Other | Phase PHASE3 | Adjunct to Hemostasis During Vascular Surgery | COMPLETED | NCT04083807 |
| Cova Monitoring System 3 | Other | Preclinical | Healthy | COMPLETED | NCT03884582 |
| Cova Monitoring System 3 | Other | Preclinical | Healthy | COMPLETED | NCT03884582 |
| MyPKFiT | Other | Approved | Hemophilia A | TERMINATED | NCT02634424 |
| Advate | Other | Phase PHASE3 | Hemophilia | COMPLETED | NCT02306694 |
| Advate | Other | Phase PHASE3 | Hemophilia | COMPLETED | NCT02306694 |
| Tachosil | Other | Approved | Air Leak From Lung | COMPLETED | NCT03450265 |
| Hemopatch | Other | Approved | Air Leak From Lung | COMPLETED | NCT03450265 |
| Tachosil | Other | Approved | Air Leak From Lung | COMPLETED | NCT03450265 |
| Hemopatch | Other | Approved | Air Leak From Lung | COMPLETED | NCT03450265 |
| Elisio-21H | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03211676 |
| Theranova-500 dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03211676 |
| Elisio-21H | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03211676 |
| Theranova-500 dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03211676 |
| Usual Care | Other | Approved | End Stage Renal Disease | UNKNOWN | NCT01643486 |
| iTouch phosphate counting program | Other | Approved | End Stage Renal Disease | UNKNOWN | NCT01643486 |
| Usual Care | Other | Approved | End Stage Renal Disease | UNKNOWN | NCT01643486 |
| iTouch phosphate counting program | Other | Approved | End Stage Renal Disease | UNKNOWN | NCT01643486 |
| Venofer Injection | Other | Phase PHASE1 | Bioequivalance | COMPLETED | NCT04155814 |
| Iron Sucrose Injection | Other | Phase PHASE1 | Bioequivalance | COMPLETED | NCT04155814 |
| Venofer Injection | Other | Phase PHASE1 | Bioequivalance | COMPLETED | NCT04155814 |
| Iron Sucrose Injection | Other | Phase PHASE1 | Bioequivalance | COMPLETED | NCT04155814 |
| Venofer Injection | Other | Phase PHASE1 | Bioequivalance | COMPLETED | NCT04155814 |
| Iron Sucrose Injection | Other | Phase PHASE1 | Bioequivalance | COMPLETED | NCT04155814 |
| Surgicel Original | Other | Approved | Bleeding Active | COMPLETED | NCT02640235 |
| CELSTAT | Other | Approved | Bleeding Active | COMPLETED | NCT02640235 |
| Surgicel Original | Other | Approved | Bleeding Active | COMPLETED | NCT02640235 |
| CELSTAT | Other | Approved | Bleeding Active | COMPLETED | NCT02640235 |
| Conventional Lung Protective Ventilation | Other | Approved | Respiratory Distress Syndrome, Adult | TERMINATED | NCT02252094 |
| Ultra-protective ventilation | Other | Approved | Respiratory Distress Syndrome, Adult | TERMINATED | NCT02252094 |
| Prismalung | Other | Approved | Respiratory Distress Syndrome, Adult | TERMINATED | NCT02252094 |
| Buttonhole needling technique | Other | Approved | Renal Failure | COMPLETED | NCT01962025 |
| Online hemodiafiltration | Other | Approved | Kidney Failure, Chronic | COMPLETED | NCT03448887 |
| Theranova | Other | Approved | Kidney Failure, Chronic | COMPLETED | NCT03448887 |
| Online hemodiafiltration | Other | Approved | Kidney Failure, Chronic | COMPLETED | NCT03448887 |
| Theranova | Other | Approved | Kidney Failure, Chronic | COMPLETED | NCT03448887 |
| ARTISS human fibrin sealant | Other | Phase PHASE2 | Subjects Requesting and Requiring an Open Rhinoplasty | COMPLETED | NCT01684020 |
| ARTISS human fibrin sealant | Other | Phase PHASE2 | Subjects Requesting and Requiring an Open Rhinoplasty | COMPLETED | NCT01684020 |
| More concentrated parenteral nutrition solution | Other | Preclinical | Nutrition Disorder, Infant | COMPLETED | NCT04085484 |
| More concentrated parenteral nutrition solution | Other | Preclinical | Nutrition Disorder, Infant | COMPLETED | NCT04085484 |
| FVIII concentrate | Other | Preclinical | Hemophilia A | COMPLETED | NCT01652027 |
| FVIII concentrate | Other | Preclinical | Hemophilia A | COMPLETED | NCT01652027 |
| FVIII concentrate | Other | Preclinical | Hemophilia A | COMPLETED | NCT01652027 |
| Assessment the activity of anti-Xa factor. | Other | Preclinical | Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis | UNKNOWN | NCT04671160 |
| Assessment the activity of anti-Xa factor. | Other | Preclinical | Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis | UNKNOWN | NCT04671160 |
| Automated peritoneal dialysis (APD) | Other | Approved | End Stage Kidney Disease | COMPLETED | NCT04017572 |
| Automated peritoneal dialysis (APD) | Other | Approved | End Stage Kidney Disease | COMPLETED | NCT04017572 |
| Olimel (5.7%E / N9E) | Other | Phase PHASE3 | Critical Illness | TERMINATED | NCT01206166 |
| Olimel (5.7%E / N9E) | Other | Phase PHASE3 | Critical Illness | TERMINATED | NCT01206166 |
| Olimel (5.7%E / N9E) | Other | Phase PHASE3 | Critical Illness | TERMINATED | NCT01206166 |
| Ropivacaine 0.4% | Other | Phase PHASE4 | Relatively Healthy Volunteers | COMPLETED | NCT01898689 |
| Ropivacaine 0.1% | Other | Phase PHASE4 | Relatively Healthy Volunteers | COMPLETED | NCT01898689 |
| Ropivacaine 0.4% | Other | Phase PHASE4 | Relatively Healthy Volunteers | COMPLETED | NCT01898689 |
| Ropivacaine 0.1% | Other | Phase PHASE4 | Relatively Healthy Volunteers | COMPLETED | NCT01898689 |
| Peripheral intravenous analysis (PIVA) algorithm | Other | Approved | Healthy Volunteers | TERMINATED | NCT04324593 |
| Peripheral intravenous analysis (PIVA) algorithm | Other | Approved | Healthy Volunteers | TERMINATED | NCT04324593 |
| Peripheral intravenous analysis (PIVA) algorithm | Other | Approved | Healthy Volunteers | TERMINATED | NCT04324593 |
| Standard noninvasive vascular monitoring | Other | Preclinical | Systemic Inflammatory Response Syndrome | TERMINATED | NCT03407287 |
| Standard of care invasive vascular monitoring | Other | Preclinical | Systemic Inflammatory Response Syndrome | TERMINATED | NCT03407287 |
| Peripheral Intravenous Analysis (PIVA) | Other | Preclinical | Systemic Inflammatory Response Syndrome | TERMINATED | NCT03407287 |
| Standard noninvasive vascular monitoring | Other | Preclinical | Systemic Inflammatory Response Syndrome | TERMINATED | NCT03407287 |
| Standard of care invasive vascular monitoring | Other | Preclinical | Systemic Inflammatory Response Syndrome | TERMINATED | NCT03407287 |
| Peripheral Intravenous Analysis (PIVA) | Other | Preclinical | Systemic Inflammatory Response Syndrome | TERMINATED | NCT03407287 |
| Intralipid | Other | Phase PHASE4 | Essential Fatty Acid Deficiency (EFAD) | TERMINATED | NCT02476994 |
| Clinolipid | Other | Phase PHASE4 | Essential Fatty Acid Deficiency (EFAD) | TERMINATED | NCT02476994 |
| Intralipid | Other | Phase PHASE4 | Essential Fatty Acid Deficiency (EFAD) | TERMINATED | NCT02476994 |
| Clinolipid | Other | Phase PHASE4 | Essential Fatty Acid Deficiency (EFAD) | TERMINATED | NCT02476994 |
| Intralipid | Other | Phase PHASE4 | Essential Fatty Acid Deficiency (EFAD) | TERMINATED | NCT02476994 |
| Clinolipid | Other | Phase PHASE4 | Essential Fatty Acid Deficiency (EFAD) | TERMINATED | NCT02476994 |
| standard preventive measures | Other | Phase PHASE3 | Prolonged Air Leak | COMPLETED | NCT02491671 |
| Hemopatch | Other | Phase PHASE3 | Prolonged Air Leak | COMPLETED | NCT02491671 |
| HomeChoice PRO | Other | Approved | Efficacy | ACTIVE_NOT_RECRUITING | NCT04002440 |
| AMIA with SHARESOURCE Connectivity Platform | Other | Approved | Efficacy | ACTIVE_NOT_RECRUITING | NCT04002440 |
| HomeChoice PRO | Other | Approved | Efficacy | ACTIVE_NOT_RECRUITING | NCT04002440 |
| AMIA with SHARESOURCE Connectivity Platform | Other | Approved | Efficacy | ACTIVE_NOT_RECRUITING | NCT04002440 |
| Theranova dialyzer | Other | Approved | End Stage Renal Failure on Dialysis | COMPLETED | NCT04106310 |
| High-flux dialyzer | Other | Approved | End Stage Renal Failure on Dialysis | COMPLETED | NCT04106310 |
| Theranova dialyzer | Other | Approved | End Stage Renal Failure on Dialysis | COMPLETED | NCT04106310 |
| High-flux dialyzer | Other | Approved | End Stage Renal Failure on Dialysis | COMPLETED | NCT04106310 |
| Theranova dialyzer | Other | Approved | End Stage Renal Failure on Dialysis | COMPLETED | NCT04106310 |
| High-flux dialyzer | Other | Approved | End Stage Renal Failure on Dialysis | COMPLETED | NCT04106310 |
| Back Side of the Moon | Other | Approved | Nutritional Deficiency | COMPLETED | NCT03724045 |
| Back Side of the Moon | Other | Approved | Nutritional Deficiency | COMPLETED | NCT03724045 |
| Telemedicine | Other | Preclinical | ESRD | COMPLETED | NCT02428803 |
| Telemedicine | Other | Preclinical | ESRD | COMPLETED | NCT02428803 |
| placebo comparator | Other | Phase PHASE4 | End-stage Renal Disease | COMPLETED | NCT00745225 |
| Pioglitazone | Other | Phase PHASE4 | End-stage Renal Disease | COMPLETED | NCT00745225 |
| placebo comparator | Other | Phase PHASE4 | End-stage Renal Disease | COMPLETED | NCT00745225 |
| Pioglitazone | Other | Phase PHASE4 | End-stage Renal Disease | COMPLETED | NCT00745225 |
| Hemopatch | Other | Phase PHASE2 | Pancreas Cancer | COMPLETED | NCT03410914 |
| Hemopatch | Other | Phase PHASE2 | Pancreas Cancer | COMPLETED | NCT03410914 |
| Sevoflurane | Other | Phase PHASE3 | Cystoscopes | COMPLETED | NCT01219881 |
| Desflurane | Other | Phase PHASE3 | Cystoscopes | COMPLETED | NCT01219881 |
| Control Therapy | Drug | Approved | Metabolism and Nutrition Disorder | COMPLETED | NCT03058107 |
| Nutrition Therapy | Drug | Approved | Metabolism and Nutrition Disorder | COMPLETED | NCT03058107 |
| Cova Patch | Other | Preclinical | Cardiac Failure | COMPLETED | NCT04255108 |
| Cova Patch | Other | Preclinical | Cardiac Failure | COMPLETED | NCT04255108 |
| Intermittent hemodialysis | Other | Approved | Acute Kidney Injury | UNKNOWN | NCT03598387 |
| Automated peritoneal dialysis | Other | Approved | Acute Kidney Injury | UNKNOWN | NCT03598387 |
| Intermittent hemodialysis | Other | Approved | Acute Kidney Injury | UNKNOWN | NCT03598387 |
| Automated peritoneal dialysis | Other | Approved | Acute Kidney Injury | UNKNOWN | NCT03598387 |
| Observational test | Other | Preclinical | Malnutrition | COMPLETED | NCT04168814 |
| Observational test | Other | Preclinical | Malnutrition | COMPLETED | NCT04168814 |
| Sodium chloride 0.9% | Other | Phase PHASE3 | ICU Delirium | COMPLETED | NCT03477344 |
| Dexmedetomidine | Other | Phase PHASE3 | ICU Delirium | COMPLETED | NCT03477344 |
| Sodium chloride 0.9% | Other | Phase PHASE3 | ICU Delirium | COMPLETED | NCT03477344 |
| Dexmedetomidine | Other | Phase PHASE3 | ICU Delirium | COMPLETED | NCT03477344 |
| Triple-effect blood purification filter | Other | Approved | Severe Septic Shock | UNKNOWN | NCT04957316 |
| Triple-effect blood purification filter | Other | Approved | Severe Septic Shock | UNKNOWN | NCT04957316 |
| Measure of quadriceps thickness with ultrasonography and albumin/prealbumin levels | Other | Approved | Malnutrition | TERMINATED | NCT02564159 |
| Measure of quadriceps thickness with ultrasonography and albumin/prealbumin levels | Other | Approved | Malnutrition | TERMINATED | NCT02564159 |
| Measure of quadriceps thickness with ultrasonography and albumin/prealbumin levels | Other | Approved | Malnutrition | TERMINATED | NCT02564159 |
| Intradialytic Parenteral Nutrition | Other | Preclinical | End-stage Renal Disease | UNKNOWN | NCT05439174 |
| Intradialytic Parenteral Nutrition | Other | Preclinical | End-stage Renal Disease | UNKNOWN | NCT05439174 |
| Intradialytic Parenteral Nutrition | Other | Preclinical | End-stage Renal Disease | UNKNOWN | NCT05439174 |
| Cefazolin | Other | Phase PHASE1 | Healthy | COMPLETED | NCT05309304 |
| Cefazolin | Other | Phase PHASE1 | Healthy | COMPLETED | NCT05309304 |
| Cefazolin | Other | Phase PHASE1 | Healthy | COMPLETED | NCT05309304 |
| Hemopatch | Other | Preclinical | Dura Mater Nick Cut or Tear | COMPLETED | NCT03392662 |
| Hemopatch | Other | Preclinical | Dura Mater Nick Cut or Tear | COMPLETED | NCT03392662 |
| Continuous renal replacement therapy with oXiris | Drug | Preclinical | Acute Kidney Injury Due to Sepsis (Disorder) | COMPLETED | NCT04073771 |
| Continuous renal replacement therapy with oXiris | Drug | Preclinical | Acute Kidney Injury Due to Sepsis (Disorder) | COMPLETED | NCT04073771 |
| maintenance with propofol | Other | Approved | Anesthesia | UNKNOWN | NCT02061514 |
| maintenance with desflurane | Other | Approved | Anesthesia | UNKNOWN | NCT02061514 |
| Tisseel® | Other | Approved | Digital Nerve Injuries | NOT_YET_RECRUITING | NCT05490940 |
| Tisseel® | Other | Approved | Digital Nerve Injuries | UNKNOWN | NCT05490940 |
| Coagulation by FLOSEAL haemostatic agent | Other | Approved | Benign Ovarian Cyst | UNKNOWN | NCT05037552 |
| Bipolar coagulation | Other | Approved | Benign Ovarian Cyst | UNKNOWN | NCT05037552 |
| Coagulation by FLOSEAL haemostatic agent | Other | Approved | Benign Ovarian Cyst | UNKNOWN | NCT05037552 |
| Bipolar coagulation | Other | Approved | Benign Ovarian Cyst | UNKNOWN | NCT05037552 |
| Coagulation by FLOSEAL haemostatic agent | Other | Approved | Benign Ovarian Cyst | NOT_YET_RECRUITING | NCT05037552 |
| Bipolar coagulation | Other | Approved | Benign Ovarian Cyst | NOT_YET_RECRUITING | NCT05037552 |
| Hemopatch | Other | Phase PHASE2 | Thoracic Surgery Lung | UNKNOWN | NCT02364791 |
| standard techniques used to achieve air leak control | Other | Phase PHASE2 | Thoracic Surgery Lung | UNKNOWN | NCT02364791 |
| Hemopatch | Other | Phase PHASE2 | Thoracic Surgery Lung | UNKNOWN | NCT02364791 |
| standard techniques used to achieve air leak control | Other | Phase PHASE2 | Thoracic Surgery Lung | UNKNOWN | NCT02364791 |
| Hemopatch | Other | Phase PHASE2 | Thoracic Surgery Lung | UNKNOWN | NCT02364791 |
| standard techniques used to achieve air leak control | Other | Phase PHASE2 | Thoracic Surgery Lung | UNKNOWN | NCT02364791 |
| Floseal | Other | Preclinical | Blood Loss | COMPLETED | NCT04058665 |
| Starling | Other | Preclinical | Hemodynamic Monitoring | WITHDRAWN | NCT05729048 |
| Starling | Other | Preclinical | Hemodynamic Monitoring | WITHDRAWN | NCT05729048 |
| 0.9% sodium chloride | Other | Phase PHASE4 | Hypovolemia | COMPLETED | NCT02721654 |
| Plasma-Lyte 148® | Other | Phase PHASE4 | Hypovolemia | COMPLETED | NCT02721654 |
| 0.9% sodium chloride | Other | Phase PHASE4 | Hypovolemia | COMPLETED | NCT02721654 |
| Plasma-Lyte 148® | Other | Phase PHASE4 | Hypovolemia | COMPLETED | NCT02721654 |
| Esmolol administration | Other | Phase PHASE2 | Septic Shock | UNKNOWN | NCT02120404 |
| Esmolol administration | Other | Phase PHASE2 | Septic Shock | UNKNOWN | NCT02120404 |
| Esmolol administration | Other | Phase PHASE2 | Septic Shock | UNKNOWN | NCT02120404 |
| Apixaban 2.5 milligram Oral Tablet | Other | Phase PHASE2 | Atrial Fibrillation | COMPLETED | NCT04952792 |
| Apixaban 2.5 milligram Oral Tablet | Other | Phase PHASE2 | Atrial Fibrillation | COMPLETED | NCT04952792 |
| Apixaban 2.5 milligram Oral Tablet | Other | Phase PHASE2 | Atrial Fibrillation | COMPLETED | NCT04952792 |
| Electrocautery | Other | Approved | Benign Ovarian Tumor | COMPLETED | NCT01683877 |
| FloSeal application | Other | Approved | Benign Ovarian Tumor | COMPLETED | NCT01683877 |
| Electrocautery | Other | Approved | Benign Ovarian Tumor | COMPLETED | NCT01683877 |
| FloSeal application | Other | Approved | Benign Ovarian Tumor | COMPLETED | NCT01683877 |
| Antibiotics | Other | Preclinical | Hemodiafiltration | COMPLETED | NCT04033029 |
| Continuous venovenous hemodiafiltration with high adsorption membrane (oXiris®) | Other | Preclinical | Hemodiafiltration | COMPLETED | NCT04033029 |
| Antibiotics | Other | Preclinical | Hemodiafiltration | COMPLETED | NCT04033029 |
| Continuous venovenous hemodiafiltration with high adsorption membrane (oXiris®) | Other | Preclinical | Hemodiafiltration | COMPLETED | NCT04033029 |
| Antibiotics | Other | Preclinical | Hemodiafiltration | COMPLETED | NCT04033029 |
| Continuous venovenous hemodiafiltration with high adsorption membrane (oXiris®) | Other | Preclinical | Hemodiafiltration | COMPLETED | NCT04033029 |
| Starling SV | Other | Preclinical | Undifferentated Shock | COMPLETED | NCT05101031 |
| Starling SV | Other | Preclinical | Undifferentated Shock | COMPLETED | NCT05101031 |
| High-flux dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT04211571 |
| Theranova 400 dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT04211571 |
| High-flux dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT04211571 |
| Theranova 400 dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT04211571 |
| Desflurane | Other | Phase PHASE4 | Renal Failure | COMPLETED | NCT03917186 |
| Sevoflurane | Other | Phase PHASE4 | Renal Failure | COMPLETED | NCT03917186 |
| CVVH using PrismafleX HF1400 filter | Other | Approved | Septic Shock | COMPLETED | NCT03426943 |
| CVVH using oXiris™ filter | Other | Approved | Septic Shock | COMPLETED | NCT03426943 |
| Ultrafiltrate sampling | Other | Approved | Septic Shock | COMPLETED | NCT03426943 |
| Arterial blood sampling | Other | Approved | Septic Shock | COMPLETED | NCT03426943 |
| CVVH using PrismafleX HF1400 filter | Other | Approved | Septic Shock | COMPLETED | NCT03426943 |
| CVVH using oXiris™ filter | Other | Approved | Septic Shock | COMPLETED | NCT03426943 |
| Ultrafiltrate sampling | Other | Approved | Septic Shock | COMPLETED | NCT03426943 |
| Arterial blood sampling | Other | Approved | Septic Shock | COMPLETED | NCT03426943 |
| CVVH using PrismafleX HF1400 filter | Other | Approved | Septic Shock | COMPLETED | NCT03426943 |
| CVVH using oXiris™ filter | Other | Approved | Septic Shock | COMPLETED | NCT03426943 |
| Ultrafiltrate sampling | Other | Approved | Septic Shock | COMPLETED | NCT03426943 |
| Arterial blood sampling | Other | Approved | Septic Shock | COMPLETED | NCT03426943 |
| Nutritional assessments | Other | Approved | Chronic Kidney Diseases | UNKNOWN | NCT05568914 |
| Bio-electrical Impedance Analysis (BIA) | Other | Approved | Chronic Kidney Diseases | UNKNOWN | NCT05568914 |
| Indirect Calorimetry | Other | Approved | Chronic Kidney Diseases | UNKNOWN | NCT05568914 |
| Nutritional assessments | Other | Approved | Chronic Kidney Diseases | RECRUITING | NCT05568914 |
| Bio-electrical Impedance Analysis (BIA) | Other | Approved | Chronic Kidney Diseases | RECRUITING | NCT05568914 |
| Indirect Calorimetry | Other | Approved | Chronic Kidney Diseases | RECRUITING | NCT05568914 |
| Nutritional assessments | Other | Approved | Chronic Kidney Diseases | UNKNOWN | NCT05568914 |
| Bio-electrical Impedance Analysis (BIA) | Other | Approved | Chronic Kidney Diseases | UNKNOWN | NCT05568914 |
| Indirect Calorimetry | Other | Approved | Chronic Kidney Diseases | UNKNOWN | NCT05568914 |
| HF20™ | Other | Preclinical | Pediatric Kidney Disease | COMPLETED | NCT04836026 |
| HF20™ | Other | Preclinical | Pediatric Kidney Disease | COMPLETED | NCT04836026 |
| HF20™ | Other | Preclinical | Pediatric Kidney Disease | COMPLETED | NCT04836026 |
| Intralipid | Other | Phase PHASE4 | Essential Fatty Acid Deficiency (EFAD) | COMPLETED | NCT04555044 |
| Clinolipid | Other | Phase PHASE4 | Essential Fatty Acid Deficiency (EFAD) | COMPLETED | NCT04555044 |
| Intralipid | Other | Phase PHASE4 | Essential Fatty Acid Deficiency (EFAD) | COMPLETED | NCT04555044 |
| Clinolipid | Other | Phase PHASE4 | Essential Fatty Acid Deficiency (EFAD) | COMPLETED | NCT04555044 |
| Ready-to-Use Parenteral Nutrition | Other | Preclinical | Very Low Birth Weight Infant | COMPLETED | NCT06200324 |
| Ready-to-Use Parenteral Nutrition | Other | Preclinical | Very Low Birth Weight Infant | COMPLETED | NCT06200324 |
| Ready-to-Use Parenteral Nutrition | Other | Preclinical | Very Low Birth Weight Infant | COMPLETED | NCT06200324 |
| Oxiris | Other | Preclinical | Acute Kidney Injury | COMPLETED | NCT04952714 |
| Adsorption membrane filter Oxiris™ | Other | Preclinical | Acute Kidney Injury | ACTIVE_NOT_RECRUITING | NCT06253377 |
| Oliclinomel N71000 OR N71000E // Clinimix N17G35 OR N17G35E | Other | Phase PHASE4 | Critical Illness | ACTIVE_NOT_RECRUITING | NCT00512122 |
| Withholding PN during the first week of ICU stay | Other | Phase PHASE4 | Critical Illness | ACTIVE_NOT_RECRUITING | NCT00512122 |
| Oliclinomel N71000 OR N71000E // Clinimix N17G35 OR N17G35E | Other | Phase PHASE4 | Critical Illness | ACTIVE_NOT_RECRUITING | NCT00512122 |
| Withholding PN during the first week of ICU stay | Other | Phase PHASE4 | Critical Illness | ACTIVE_NOT_RECRUITING | NCT00512122 |
| Extracorporeal carbon dioxide removal | Other | Preclinical | ARDS, Human | RECRUITING | NCT06321497 |
| Extracorporeal carbon dioxide removal | Other | Preclinical | ARDS, Human | RECRUITING | NCT06321497 |
| propofol | Other | Approved | Lung Cancer | ACTIVE_NOT_RECRUITING | NCT02324283 |
| desflurane | Other | Approved | Lung Cancer | ACTIVE_NOT_RECRUITING | NCT02324283 |
| propofol | Other | Approved | Lung Cancer | ACTIVE_NOT_RECRUITING | NCT02324283 |
| desflurane | Other | Approved | Lung Cancer | ACTIVE_NOT_RECRUITING | NCT02324283 |
| Starling | Other | Preclinical | Hemodynamic Monitoring | COMPLETED | NCT04648293 |
| Hypertonic Dextrose solution | Other | Phase PHASE4 | Peritoneal Dialysis | RECRUITING | NCT05721404 |
| Icodextrin Peritoneal Dialysis Solution | Other | Phase PHASE4 | Peritoneal Dialysis | RECRUITING | NCT05721404 |
| Hypertonic Dextrose solution | Other | Phase PHASE4 | Peritoneal Dialysis | RECRUITING | NCT05721404 |
| Icodextrin Peritoneal Dialysis Solution | Other | Phase PHASE4 | Peritoneal Dialysis | RECRUITING | NCT05721404 |
| Supplemental parenteral nutrition | Other | Phase PHASE2 | Critical Illness | COMPLETED | NCT03292237 |
| No Intervention | Other | Approved | Congenital Heart Disease in Children | ACTIVE_NOT_RECRUITING | NCT05647161 |
| BAX602 | Other | Approved | Congenital Heart Disease in Children | ACTIVE_NOT_RECRUITING | NCT05647161 |
| Implementation of the KDIGO bundle) | Other | Approved | Acute Kidney Injury (Nontraumatic) | RECRUITING | NCT05275218 |
| Invasive Reference Equipment | Other | Approved | Blood Pressure | RECRUITING | NCT05976425 |
| ModPG3 Investigational Device | Device | Approved | Blood Pressure | RECRUITING | NCT05976425 |
| Usual care | Other | Approved | Nutritional Support | RECRUITING | NCT06342895 |
| Nutritional support prescription and delivery monitoring feedback | Other | Approved | Nutritional Support | RECRUITING | NCT06342895 |
| Usual care | Other | Approved | Nutritional Support | RECRUITING | NCT06342895 |
| Nutritional support prescription and delivery monitoring feedback | Other | Approved | Nutritional Support | RECRUITING | NCT06342895 |
| Increased Body Temperatures | Other | Preclinical | Body Temperature Changes | ACTIVE_NOT_RECRUITING | NCT06556628 |
| Increased Body Temperatures | Other | Preclinical | Body Temperature Changes | ACTIVE_NOT_RECRUITING | NCT06556628 |
| Increased Body Temperatures | Other | Preclinical | Body Temperature Changes | ACTIVE_NOT_RECRUITING | NCT06556628 |
| 0.9% SODIUM CHLORIDE 9g/L injection BP | Other | Phase PHASE3 | End Stage Kidney Disease | COMPLETED | NCT03829488 |
| Plasma-Lyte 148 (approx. pH 7.4) IV Infusion | Other | Phase PHASE3 | End Stage Kidney Disease | COMPLETED | NCT03829488 |
| 0.9% SODIUM CHLORIDE 9g/L injection BP | Other | Phase PHASE3 | End Stage Kidney Disease | COMPLETED | NCT03829488 |
| Plasma-Lyte 148 (approx. pH 7.4) IV Infusion | Other | Phase PHASE3 | End Stage Kidney Disease | COMPLETED | NCT03829488 |
| 0.9% SODIUM CHLORIDE 9g/L injection BP | Other | Phase PHASE3 | End Stage Kidney Disease | COMPLETED | NCT03829488 |
| Plasma-Lyte 148 (approx. pH 7.4) IV Infusion | Other | Phase PHASE3 | End Stage Kidney Disease | COMPLETED | NCT03829488 |
| 0.9% SODIUM CHLORIDE 9g/L injection BP | Other | Phase PHASE3 | End Stage Kidney Disease | COMPLETED | NCT03829488 |
| Plasma-Lyte 148 (approx. pH 7.4) IV Infusion | Other | Phase PHASE3 | End Stage Kidney Disease | COMPLETED | NCT03829488 |
| oXiris® | Other | Approved | Cardiopulmonary Bypass | COMPLETED | NCT02518087 |
| oXiris® | Other | Approved | Cardiopulmonary Bypass | COMPLETED | NCT02518087 |
| oXiris® | Other | Approved | Cardiopulmonary Bypass | COMPLETED | NCT02518087 |
| Passive leg raise (PLR) | Other | Preclinical | Infection | TERMINATED | NCT03736421 |
| Non-invasive fluid response measure | Other | Preclinical | Infection | TERMINATED | NCT03736421 |
| Peripheral Intravenous Analysis (PIVA) | Other | Preclinical | Infection | TERMINATED | NCT03736421 |
| Critically ill patients with continuous renal replacement therapy | Drug | Preclinical | Critically Ill | RECRUITING | NCT05450185 |
| Critically ill patients with continuous renal replacement therapy | Drug | Preclinical | Critically Ill | RECRUITING | NCT05450185 |
| Theranova Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03640858 |
| Theranova Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03640858 |
| Theranova Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03640858 |
| Adhesion barrier | Other | Approved | Adhesive Small Bowel Obstruction | NOT_YET_RECRUITING | NCT06777446 |
| Elective Adhesionlysis | Other | Approved | Adhesive Small Bowel Obstruction | NOT_YET_RECRUITING | NCT06777446 |
| Adhesion barrier | Other | Approved | Adhesive Small Bowel Obstruction | NOT_YET_RECRUITING | NCT06777446 |
| Elective Adhesionlysis | Other | Approved | Adhesive Small Bowel Obstruction | NOT_YET_RECRUITING | NCT06777446 |
| Theranova Dialyzer | Other | Approved | End Stage Renal Disease | RECRUITING | NCT06032208 |
| Theranova Dialyzer | Other | Approved | End Stage Renal Disease | RECRUITING | NCT06032208 |
| Theranova Dialyzer | Other | Approved | End Stage Renal Disease | RECRUITING | NCT06032208 |
| Artis Haemodialysis Machine w/o ASIST Software | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT02795286 |
| Artis Haemodialysis Machine w/ ASIST Software - Isotonic | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT02795286 |
| Artis Haemodialysis Machine w/ ASIST Software - Isonatremic | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT02795286 |
| Artis Haemodialysis Machine w/o ASIST Software | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT02795286 |
| Artis Haemodialysis Machine w/ ASIST Software - Isotonic | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT02795286 |
| Artis Haemodialysis Machine w/ ASIST Software - Isonatremic | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT02795286 |
| Peritoneal Dialysis treatment (no specific drug is defined) | Drug | Phase PHASE4 | End Stage Renal Disease | COMPLETED | NCT02378350 |
| Hemodialysis treatment (no specific device is defined) | Drug | Phase PHASE4 | End Stage Renal Disease | COMPLETED | NCT02378350 |
| Peritoneal Dialysis treatment (no specific drug is defined) | Drug | Phase PHASE4 | End Stage Renal Disease | COMPLETED | NCT02378350 |
| Hemodialysis treatment (no specific device is defined) | Drug | Phase PHASE4 | End Stage Renal Disease | COMPLETED | NCT02378350 |
| Peritoneal Dialysis treatment (no specific drug is defined) | Drug | Phase PHASE4 | End Stage Renal Disease | COMPLETED | NCT02378350 |
| Hemodialysis treatment (no specific device is defined) | Drug | Phase PHASE4 | End Stage Renal Disease | COMPLETED | NCT02378350 |
| Peritoneal Dialysis treatment (no specific drug is defined) | Drug | Phase PHASE4 | End Stage Renal Disease | COMPLETED | NCT02378350 |
| Hemodialysis treatment (no specific device is defined) | Drug | Phase PHASE4 | End Stage Renal Disease | COMPLETED | NCT02378350 |
| FX CorDiax 800 Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02377622 |
| FX CorDiax 80 Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02377622 |
| THERANOVA 400 dialyzer prototype BB | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02377622 |
| THERANOVA 400 dialyzer prototype AA | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02377622 |
| FX CorDiax 800 Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02377622 |
| FX CorDiax 80 Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02377622 |
| THERANOVA 400 dialyzer prototype BB | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02377622 |
| THERANOVA 400 dialyzer prototype AA | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02377622 |
| FX CorDiax 80 dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02377570 |
| THERNOVA 400 dialyzer prototype CC | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02377570 |
| THERANOVA 400 dialyzer prototype BB | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02377570 |
| THERANOVA 400 dialyzer prototype AA | Other | Approved | End Stage Renal Disease | COMPLETED | NCT02377570 |
| Revaclear 400 | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT02084381 |
| MCO-Ci 400 | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT02084381 |
| Revaclear 400 | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT02084381 |
| MCO-Ci 400 | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT02084381 |
| Evodial+ Condition C | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT01783626 |
| Evodial+ Condition B2 | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT01783626 |
| Evodial+ Condition B1 | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT01783626 |
| Evodial | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT01783626 |
| Evodial+ Condition C | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT01783626 |
| Evodial+ Condition B2 | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT01783626 |
| Evodial+ Condition B1 | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT01783626 |
| Evodial | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT01783626 |
| Experimental Peritoneal Dialysis Solution | Other | Approved | End Stage Renal Disease | COMPLETED | NCT00214695 |
| Experimental Peritoneal Dialysis Solution | Other | Approved | End Stage Renal Disease | COMPLETED | NCT00214695 |
| Extraneal (7.5% icodextrin) Peritoneal Dialysis Solution | Other | Phase PHASE4 | Peritoneal Dialysis | WITHDRAWN | NCT00397358 |
| Extraneal (7.5% icodextrin) Peritoneal Dialysis Solution | Other | Phase PHASE4 | Peritoneal Dialysis | WITHDRAWN | NCT00397358 |
| Extraneal (7.5% icodextrin) Peritoneal Dialysis Solution | Other | Phase PHASE4 | Peritoneal Dialysis | WITHDRAWN | NCT00397358 |
| Standard Medical Therapy | Drug | Approved | Hepatic Encephalopathy | COMPLETED | NCT00287235 |
| MARS | Other | Approved | Hepatic Encephalopathy | COMPLETED | NCT00287235 |
| Standard Medical Therapy | Drug | Approved | Hepatic Encephalopathy | COMPLETED | NCT00287235 |
| MARS | Other | Approved | Hepatic Encephalopathy | COMPLETED | NCT00287235 |
| Experimental Peritoneal Dialysis Solution | Other | Phase PHASE3 | End Stage Renal Disease | COMPLETED | NCT00214721 |
| Experimental Peritoneal Dialysis Solution | Other | Phase PHASE3 | End Stage Renal Disease | COMPLETED | NCT00214721 |
| On line hemodiafiltration | Other | Approved | Chronic Renal Failure | COMPLETED | NCT01202708 |
| On line hemofiafiltration | Other | Approved | Chronic Renal Failure | COMPLETED | NCT01202708 |
| On line hemodiafiltration | Other | Approved | Chronic Renal Failure | COMPLETED | NCT01202708 |
| On line hemofiafiltration | Other | Approved | Chronic Renal Failure | COMPLETED | NCT01202708 |
| Gambro HD-C4 Small Dialyzer | Other | Preclinical | Hemodialysis | COMPLETED | NCT00579202 |
| Gambro HD-C4 Small Dialyzer | Other | Preclinical | Hemodialysis | COMPLETED | NCT00579202 |
| Vascular access catheter to support dialysis or CRRT | Other | Preclinical | AKI - Acute Kidney Injury | COMPLETED | NCT05888376 |
| Vascular access catheter to support dialysis or CRRT | Other | Preclinical | AKI - Acute Kidney Injury | COMPLETED | NCT05888376 |
| Vascular access catheter to support dialysis or CRRT | Other | Preclinical | AKI - Acute Kidney Injury | COMPLETED | NCT05888376 |
| AK200 Ultra S, extracorporeal circulation conduct of blood purification | Other | Approved | End-Stage Renal Disease | COMPLETED | NCT03859830 |
| Artis Dialysis System, ArtiSet PrePost and Ultra HDF Line | Other | Approved | End-Stage Renal Disease | COMPLETED | NCT03859830 |
| FX800 Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03547336 |
| Theranova 400 Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03547336 |
| FX800 Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03547336 |
| Theranova 400 Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03547336 |
| FX800 Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03547336 |
| Theranova 400 Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03547336 |
| FX80 Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03547323 |
| Theranova 400 Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03547323 |
| FX80 Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03547323 |
| Theranova 400 Dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03547323 |
| Hemodiafiltration | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03499691 |
| Theranova 500 medium cut-off dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03499691 |
| Hemodiafiltration | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03499691 |
| Theranova 500 medium cut-off dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03499691 |
| Artis Haemodialysis Machine w/o ASIST Software | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT02795286 |
| Artis Haemodialysis Machine w/ ASIST Software - Isotonic | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT02795286 |
| Artis Haemodialysis Machine w/ ASIST Software - Isonatremic | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT02795286 |
| Artis Haemodialysis Machine w/o ASIST Software | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT02795286 |
| Artis Haemodialysis Machine w/ ASIST Software - Isotonic | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT02795286 |
| Artis Haemodialysis Machine w/ ASIST Software - Isonatremic | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT02795286 |
| Dialyzer comparison | Other | Approved | Renal Failure Chronic Requiring Hemodialysis | COMPLETED | NCT01722695 |
| Dialyzer comparison | Other | Approved | Renal Failure Chronic Requiring Hemodialysis | COMPLETED | NCT01722695 |
| Dialyzer comparison | Other | Approved | Renal Failure Chronic Requiring Hemodialysis | COMPLETED | NCT01722695 |
| P210H | Other | Approved | End Stage Renal Disease | COMPLETED | NCT01582893 |
| HCO1100 | Other | Approved | End Stage Renal Disease | COMPLETED | NCT01582893 |
| P210H | Other | Approved | End Stage Renal Disease | COMPLETED | NCT01582893 |
| HCO1100 | Other | Approved | End Stage Renal Disease | COMPLETED | NCT01582893 |
| ARTIS hemodialysis system | Other | Approved | Renal Failure | COMPLETED | NCT01582867 |
| ARTIS hemodialysis system | Other | Approved | Renal Failure | COMPLETED | NCT01582867 |
| ARTIS hemodialysis system | Other | Approved | Renal Failure | COMPLETED | NCT01582867 |
| standard therapy | Drug | Approved | Systemic Inflammatory Response Syndrome | WITHDRAWN | NCT01579396 |
| septeX | Other | Approved | Systemic Inflammatory Response Syndrome | WITHDRAWN | NCT01579396 |
| standard therapy | Drug | Approved | Systemic Inflammatory Response Syndrome | WITHDRAWN | NCT01579396 |
| septeX | Other | Approved | Systemic Inflammatory Response Syndrome | WITHDRAWN | NCT01579396 |
| Conventional high-flux dialyzer | Other | Approved | End-Stage Renal Disease (ESRD) | COMPLETED | NCT01526798 |
| Theralite (high cut-off hemodialysis) | Other | Approved | End-Stage Renal Disease (ESRD) | COMPLETED | NCT01526798 |
| Conventional high-flux dialyzer | Other | Approved | End-Stage Renal Disease (ESRD) | COMPLETED | NCT01526798 |
| Theralite (high cut-off hemodialysis) | Other | Approved | End-Stage Renal Disease (ESRD) | COMPLETED | NCT01526798 |
| HF CVVH | Other | Approved | Rhabdomyolysis | COMPLETED | NCT01467180 |
| septeX | Other | Approved | Rhabdomyolysis | COMPLETED | NCT01467180 |
| HF CVVH | Other | Approved | Rhabdomyolysis | COMPLETED | NCT01467180 |
| septeX | Other | Approved | Rhabdomyolysis | COMPLETED | NCT01467180 |
| HF CVVH | Other | Approved | Rhabdomyolysis | COMPLETED | NCT01467180 |
| septeX | Other | Approved | Rhabdomyolysis | COMPLETED | NCT01467180 |
| HCO 1100 | Other | Approved | Cardiovascular Disease | TERMINATED | NCT01363921 |
| HCO 1100 | Other | Approved | Cardiovascular Disease | TERMINATED | NCT01363921 |
| Heparin dose titration | Other | Approved | Renal Failure Chronic Requiring Hemodialysis | COMPLETED | NCT01181544 |
| Heparin dose titration | Other | Approved | Renal Failure Chronic Requiring Hemodialysis | COMPLETED | NCT01181544 |
| Measure of peritoneal ultrafiltrates | Other | Phase PHASE4 | End Stage Renal Disease | WITHDRAWN | NCT01093547 |
| Blood samples | Other | Phase PHASE4 | End Stage Renal Disease | WITHDRAWN | NCT01093547 |
| Measure of peritoneal ultrafiltrates | Other | Phase PHASE4 | End Stage Renal Disease | WITHDRAWN | NCT01093547 |
| Blood samples | Other | Phase PHASE4 | End Stage Renal Disease | WITHDRAWN | NCT01093547 |
| Standard treatment | Drug | Approved | Sepsis | COMPLETED | NCT00922870 |
| Cascade | Other | Approved | Sepsis | COMPLETED | NCT00922870 |
| Standard treatment | Drug | Approved | Sepsis | COMPLETED | NCT00922870 |
| Cascade | Other | Approved | Sepsis | COMPLETED | NCT00922870 |
| continuous venovenous hemodialysis | Other | Approved | Systemic Inflammatory Response Syndrome | TERMINATED | NCT00875888 |
| continuous venovenous hemodialysis | Other | Approved | Systemic Inflammatory Response Syndrome | TERMINATED | NCT00875888 |
| Standard blood line | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT00804453 |
| Cartridge blood set | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT00804453 |
| Standard blood line | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT00804453 |
| Cartridge blood set | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT00804453 |
| Standard blood line | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT00804453 |
| Cartridge blood set | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT00804453 |
| Evodial hemodialysers and Evodia blood lines | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT00781690 |
| Evodial hemodialysers and Evodia blood lines | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT00781690 |
| GamCath Dolphin® Protect central venous catheter | Other | Approved | Renal Insufficiency | COMPLETED | NCT00621712 |
| GamCath® central venous catheter | Other | Approved | Renal Insufficiency | COMPLETED | NCT00621712 |
| GamCath Dolphin® Protect central venous catheter | Other | Approved | Renal Insufficiency | COMPLETED | NCT00621712 |
| GamCath® central venous catheter | Other | Approved | Renal Insufficiency | COMPLETED | NCT00621712 |
| GamCath Dolphin® Protect central venous catheter | Other | Approved | Renal Insufficiency | COMPLETED | NCT00621712 |
| GamCath® central venous catheter | Other | Approved | Renal Insufficiency | COMPLETED | NCT00621712 |
| GamCath Dolphin® Protect central venous catheter | Other | Approved | Hemodialysis | COMPLETED | NCT00621114 |
| GamCath® central venous catheter | Other | Approved | Hemodialysis | COMPLETED | NCT00621114 |
| GamCath Dolphin® Protect central venous catheter | Other | Approved | Hemodialysis | COMPLETED | NCT00621114 |
| GamCath® central venous catheter | Other | Approved | Hemodialysis | COMPLETED | NCT00621114 |
| Standard medical therapy | Drug | Approved | Liver Failure | COMPLETED | NCT00614146 |
| MARS device | Device | Approved | Liver Failure | COMPLETED | NCT00614146 |
| Standard medical therapy | Drug | Approved | Liver Failure | COMPLETED | NCT00614146 |
| MARS device | Device | Approved | Liver Failure | COMPLETED | NCT00614146 |
| Standard medical therapy | Drug | Approved | Liver Failure | COMPLETED | NCT00614146 |
| MARS device | Device | Approved | Liver Failure | COMPLETED | NCT00614146 |
| Evodial | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT01318486 |
| Heparin free dialysis technique | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT01318486 |
| Evodial | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT01318486 |
| Heparin free dialysis technique | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT01318486 |
| Glucose Peritoneal Dialysis Solution | Other | Preclinical | Chronic Renal Failure | RECRUITING | NCT06492031 |
| Icodextrin Peritoneal Dialysis Solution | Other | Preclinical | Chronic Renal Failure | RECRUITING | NCT06492031 |
| ADEPT | Other | Preclinical | Adhesion | COMPLETED | NCT05811585 |
| ADEPT | Other | Preclinical | Adhesion | COMPLETED | NCT05811585 |
| Conventional wound dressings | Other | Preclinical | Wound of Skin | TERMINATED | NCT05330767 |
| DermaClose XL Continuous External Tissue Expander Device | Device | Preclinical | Wound of Skin | TERMINATED | NCT05330767 |
| DermaClose Continuous External Tissue Expander Device | Device | Preclinical | Wound of Skin | TERMINATED | NCT05330767 |
| Conventional wound dressings | Other | Preclinical | Wound of Skin | TERMINATED | NCT05330767 |
| DermaClose XL Continuous External Tissue Expander Device | Device | Preclinical | Wound of Skin | TERMINATED | NCT05330767 |
| DermaClose Continuous External Tissue Expander Device | Device | Preclinical | Wound of Skin | TERMINATED | NCT05330767 |
| Hemodialysis sessions | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT05309109 |
| Hemodialysis sessions | Other | Approved | End Stage Renal Disease (ESRD) | COMPLETED | NCT05309109 |
| Volara therapy | Drug | Approved | Bronchiectasis Adult | NOT_YET_RECRUITING | NCT06937216 |
| Volara therapy | Drug | Approved | Bronchiectasis Adult | NOT_YET_RECRUITING | NCT06937216 |
| Compounded Parenteral Nutrition (cPN) solution | Other | Phase PHASE3 | Malnutrition, Infant | WITHDRAWN | NCT06894446 |
| Numeta G13%E | Other | Phase PHASE3 | Malnutrition, Infant | WITHDRAWN | NCT06894446 |
| Parenteral nutrition | Other | Approved | Neoplasms | COMPLETED | NCT02828150 |
| Parenteral nutrition | Other | Approved | Neoplasms | COMPLETED | NCT02828150 |
| Parenteral nutrition | Other | Approved | Neoplasms | COMPLETED | NCT02828150 |
| DOXIL/CAELYX | Other | Phase PHASE1 | Ovarian Cancer | COMPLETED | NCT05567601 |
| DOXIL/CAELYX | Other | Phase PHASE1 | Ovarian Cancer | COMPLETED | NCT05567601 |
| Sodium Glycerophosphate Injection | Other | Phase PHASE1 | Parenteral Nutrition | COMPLETED | NCT06842134 |
| Numeta G16%E | Other | Phase PHASE1 | Parenteral Nutrition | COMPLETED | NCT06842134 |
| Sodium Phosphates Injection | Other | Phase PHASE1 | Parenteral Nutrition | COMPLETED | NCT06842121 |
| Sodium Glycerophosphate Injection | Other | Phase PHASE1 | Parenteral Nutrition | COMPLETED | NCT06842121 |
| FX 800 Dialyzer | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT05309291 |
| Theranova 400 Dialyzer | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT05309291 |
| FX 800 Dialyzer | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT05309291 |
| Theranova 400 Dialyzer | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT05309291 |
| FX 800 Dialyzer | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT05309291 |
| Theranova 400 Dialyzer | Other | Approved | Chronic Kidney Failure | COMPLETED | NCT05309291 |
| AMIA APD Solution Generation System | Other | Approved | End Stage Renal Disease (ESRD) | TERMINATED | NCT03812679 |
| AMIA APD Solution Generation System | Other | Approved | End Stage Renal Disease (ESRD) | TERMINATED | NCT03812679 |
| AMIA APD Solution Generation System | Other | Approved | End Stage Renal Disease (ESRD) | TERMINATED | NCT03812679 |
| Elisio-17H dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03257410 |
| Theranova 400 dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03257410 |
| Elisio-17H dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03257410 |
| Theranova 400 dialyzer | Other | Approved | End Stage Renal Disease | COMPLETED | NCT03257410 |
| Prismaflex® System 7.10 and 7.20 | Other | Approved | Acute Kidney Injury in Pediatric Patients | TERMINATED | NCT02561247 |
| Prismaflex HF20 CRRT Filter | Other | Approved | Acute Kidney Injury in Pediatric Patients | TERMINATED | NCT02561247 |
| Prismaflex® System 7.10 and 7.20 | Other | Approved | Acute Kidney Injury in Pediatric Patients | TERMINATED | NCT02561247 |
| Prismaflex HF20 CRRT Filter | Other | Approved | Acute Kidney Injury in Pediatric Patients | TERMINATED | NCT02561247 |
| Polyflux HD-C4 | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT00636389 |
| Polyflux 210H dialyzer | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT00636389 |
| Polyflux HD-C4 | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT00636389 |
| Polyflux 210H dialyzer | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT00636389 |
| Optiflux 200NR | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT00636077 |
| Optiflux 160NR | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT00636077 |
| HD-C4 Small | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT00636077 |
| Polyflux HD-C4 Big | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT00636077 |
| Extraneal | Other | Phase PHASE2 | Congestive Heart Failure | TERMINATED | NCT00368641 |
| Extraneal | Other | Phase PHASE2 | Congestive Heart Failure | TERMINATED | NCT00368641 |
| Extraneal | Other | Phase PHASE2 | Congestive Heart Failure | TERMINATED | NCT00368641 |
| No Anticoagulation | Other | Phase PHASE3 | Regional Citrate Anticoagulation (RCA) | TERMINATED | NCT02860130 |
| Prismocitrate 18 | Other | Phase PHASE3 | Regional Citrate Anticoagulation (RCA) | TERMINATED | NCT02860130 |
| No Anticoagulation | Other | Phase PHASE3 | Regional Citrate Anticoagulation (RCA) | TERMINATED | NCT02860130 |
| Prismocitrate 18 | Other | Phase PHASE3 | Regional Citrate Anticoagulation (RCA) | TERMINATED | NCT02860130 |
| Nutrineal | Other | Phase PHASE4 | ESRD | COMPLETED | NCT00567489 |
| Extraneal | Other | Phase PHASE4 | ESRD | COMPLETED | NCT00567489 |
| Dianeal | Other | Phase PHASE4 | ESRD | COMPLETED | NCT00567489 |
| Physioneal | Other | Phase PHASE4 | ESRD | COMPLETED | NCT00567489 |
| Nutrineal | Other | Phase PHASE4 | ESRD | COMPLETED | NCT00567489 |
| Extraneal | Other | Phase PHASE4 | ESRD | COMPLETED | NCT00567489 |
| Dianeal | Other | Phase PHASE4 | ESRD | COMPLETED | NCT00567489 |
| Physioneal | Other | Phase PHASE4 | ESRD | COMPLETED | NCT00567489 |
| Nutrineal | Other | Phase PHASE3 | ESRD | COMPLETED | NCT00567398 |
| Extraneal | Other | Phase PHASE3 | ESRD | COMPLETED | NCT00567398 |
| Physioneal | Other | Phase PHASE3 | ESRD | COMPLETED | NCT00567398 |
| Dianeal | Other | Phase PHASE3 | ESRD | COMPLETED | NCT00567398 |
| Nutrineal | Other | Phase PHASE3 | ESRD | COMPLETED | NCT00567398 |
| Extraneal | Other | Phase PHASE3 | ESRD | COMPLETED | NCT00567398 |
| Physioneal | Other | Phase PHASE3 | ESRD | COMPLETED | NCT00567398 |
| Dianeal | Other | Phase PHASE3 | ESRD | COMPLETED | NCT00567398 |
| Nutrineal | Other | Phase PHASE3 | ESRD | COMPLETED | NCT00567398 |
| Extraneal | Other | Phase PHASE3 | ESRD | COMPLETED | NCT00567398 |
| Physioneal | Other | Phase PHASE3 | ESRD | COMPLETED | NCT00567398 |
| Dianeal | Other | Phase PHASE3 | ESRD | COMPLETED | NCT00567398 |
| Dianeal, Extraneal, Nutrineal | Other | Phase PHASE3 | End Stage Renal Disease (ESRD) | COMPLETED | NCT01219959 |
| Dianeal | Other | Phase PHASE3 | End Stage Renal Disease (ESRD) | COMPLETED | NCT01219959 |
| Dianeal, Extraneal, Nutrineal | Other | Phase PHASE3 | End Stage Renal Disease (ESRD) | COMPLETED | NCT01219959 |
| Dianeal | Other | Phase PHASE3 | End Stage Renal Disease (ESRD) | COMPLETED | NCT01219959 |
| Dialysis Flow Rate Start 800mL/min | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT00962000 |
| Dialysis Flow Rate Start 600mL/min | Other | Approved | Chronic Kidney Disease | COMPLETED | NCT00962000 |
| Ostene | Other | Preclinical | Intraoperative Complications | ENROLLING_BY_INVITATION | NCT06450834 |
| Ostene | Other | Preclinical | Intraoperative Complications | ENROLLING_BY_INVITATION | NCT06450834 |
| Oscillation and Lung Expansion (OLE) therapy | Drug | Approved | Neuromuscular Diseases | TERMINATED | NCT05366010 |
| Oscillation and Lung Expansion (OLE) therapy | Drug | Approved | Neuromuscular Diseases | TERMINATED | NCT05366010 |
| Coseal | Other | Preclinical | Adhesion | COMPLETED | NCT05996809 |
| Coseal | Other | Preclinical | Adhesion | COMPLETED | NCT05996809 |
| Standard Nutrition Care | Other | Approved | Malnutrition | RECRUITING | NCT03926949 |
| Parenteral Nutrition | Other | Approved | Malnutrition | RECRUITING | NCT03926949 |
| Standard Nutrition Care | Other | Approved | Malnutrition | RECRUITING | NCT03926949 |
| Parenteral Nutrition | Other | Approved | Malnutrition | RECRUITING | NCT03926949 |
| PrismaLung+ | Other | Approved | Mild to Moderate Acute Respiratory Distress Syndrome | COMPLETED | NCT04617093 |
| PrismaLung+ | Other | Approved | Mild to Moderate Acute Respiratory Distress Syndrome | COMPLETED | NCT04617093 |
| Mobile Cardiac Telemetry (MCT System) | Other | Preclinical | Healthy | COMPLETED | NCT07158333 |
| Mobile Cardiac Telemetry (MCT System) | Other | Preclinical | Healthy | COMPLETED | NCT07158333 |
| Adhesive | Other | Approved | Adhesive Wear Time | RECRUITING | NCT07256951 |
| Adhesive | Other | Approved | Adhesive Wear Time | RECRUITING | NCT07256951 |
| Adhesive | Other | Approved | Adhesive Wear Time | RECRUITING | NCT07256951 |
| PrisMax System Version 3.x with calcium line accessory | Other | Phase PHASE3 | Regional Citrate Anticoagulation (RCA) | RECRUITING | NCT05399537 |
| Prismocitrate 18 | Other | Phase PHASE3 | Regional Citrate Anticoagulation (RCA) | RECRUITING | NCT05399537 |
| Hemofiltration membranes (the oXiris membrane® and the HF1400® membrane) | Other | Preclinical | Sepsis | RECRUITING | NCT06440317 |
| Hemofiltration membranes (the oXiris membrane® and the HF1400® membrane) | Other | Preclinical | Sepsis | RECRUITING | NCT06440317 |
| Glucose IV | Other | Phase PHASE4 | End Stage Renal Disease | ACTIVE_NOT_RECRUITING | NCT04094038 |
| Olimel N12 | Other | Phase PHASE4 | End Stage Renal Disease | ACTIVE_NOT_RECRUITING | NCT04094038 |
| Glucose IV | Other | Phase PHASE4 | End Stage Renal Disease | ACTIVE_NOT_RECRUITING | NCT04094038 |
| Olimel N12 | Other | Phase PHASE4 | End Stage Renal Disease | ACTIVE_NOT_RECRUITING | NCT04094038 |
| Prismaflex HF20 | Other | Preclinical | Acute Renal Failure (ARF) | COMPLETED | NCT06633029 |
| Prismaflex HF20 | Other | Preclinical | Acute Renal Failure (ARF) | COMPLETED | NCT06633029 |
| Prismaflex HF20 | Other | Preclinical | Acute Renal Failure (ARF) | COMPLETED | NCT06633029 |
| Hemodialysis treatment | Drug | Approved | End Stage Renal Disease | TERMINATED | NCT01413074 |
| Peritoneal Dialysis treatment | Drug | Approved | End Stage Renal Disease | TERMINATED | NCT01413074 |
| Hemodialysis treatment | Drug | Approved | End Stage Renal Disease | TERMINATED | NCT01413074 |
| Peritoneal Dialysis treatment | Drug | Approved | End Stage Renal Disease | TERMINATED | NCT01413074 |
| Connex CVSM with Timmy3 module | Other | Approved | Febrile Illness | COMPLETED | NCT06056011 |
| Connex CVSM with Timmy3 module | Other | Approved | Febrile Illness | COMPLETED | NCT06056011 |
| PrisMax System Version 3.x with calcium line accessory | Other | Phase PHASE3 | Regional Citrate Anticoagulation (RCA) | RECRUITING | NCT05399537 |
| Prismocitrate 18 | Other | Phase PHASE3 | Regional Citrate Anticoagulation (RCA) | RECRUITING | NCT05399537 |
| PrisMax System Version 3.x with calcium line accessory | Other | Phase PHASE3 | Regional Citrate Anticoagulation (RCA) | RECRUITING | NCT05399537 |
| Prismocitrate 18 | Other | Phase PHASE3 | Regional Citrate Anticoagulation (RCA) | RECRUITING | NCT05399537 |
| Glucose Peritoneal Dialysis Solution | Other | Preclinical | Chronic Renal Failure | COMPLETED | NCT06492031 |
| Icodextrin Peritoneal Dialysis Solution | Other | Preclinical | Chronic Renal Failure | COMPLETED | NCT06492031 |
Total products: 884